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Lung cancer is the leading cause of cancer related death in the United 
States and worldwide. Five-year survival rates for non-small cell lung carcinoma 
patients have not improved in decades, and a majority of patients succumb to 
metastasis. Identification of therapeutic targets for metastatic disease is essential 
for the development of novel therapies. However, current 2-dimensional (2D) in 
vitro models are not reflective of the tumor microenvironment (TME) and are 
inadequate in identifying therapeutic targets.  
We adapted a 3-dimensional (3D) extracellular matrix (ECM) in vitro 
model to a hypoxic incubator to approximate physiological hypoxia of the TME in 
a microenvironment mimetic culture system. Our overall objective is to determine 
how ECM interactions with lung adenocarcinoma cells can promote hallmarks of 
cancer metastasis in a physiologically relevant in vitro system. We assessed 
three interactions within the TME: the interaction of cancer cells with ECM, the 
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interaction of cancer associated stroma with ECM, and the influence of 
environment on ECM remodeling. 
Using established and primary cell lines to produce cell-derived ECM 
(CDM), we found that lung carcinoma cells grown on 3D CDM adopt a 
mesenchymal mode of 3D migration and are significantly more invasive 
compared to 2D. The invasive phenotype was attenuated by inhibitors 
downstream of “outside-in” integrin signaling including focal adhesion kinase and 
Src family kinases. 3D CDM and physiological hypoxia enhanced the isolation 
and proliferation of primary tumor stroma isolated from cancer resections of early 
stage patients. Patient derived cell lines maintained a stem-like phenotype and 
expression of tumor promoting factors in an environment dependent manner. 
Further, they promoted metastasis in a xenograft model and CDM produced from 
patient derived stroma altered invasive characteristics in cancer cells compared 
to normal lung fibroblast CDM.       
Using our microenvironment mimetic model, we demonstrate that we can 
study ECM-to-cell interactions in a way not possible for traditional 2D models. 
These interactions play a pivotal role in determining the fate of cancer cells and 
modulate metastatic potential. Understanding how remodeling of the TME is 
involved in late stage disease will allow development of preventative and curative 
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CHAPTER I: INTRODUCTION 
Lung cancer characteristics and mortality 
Of the solid malignancies, lung cancer accounts for the greatest number of 
new cancer diagnoses worldwide with an estimated 2.1 million new cases in 
2018 (Siegel, Miller, & Jemal, 2019). It is the most commonly diagnosed cancer 
in men, and second most commonly diagnosed cancer in women after breast 
cancer. Unfortunately, this particularly insidious disease is the leading cause of 
cancer related death in men and often the leading cause of death in women each 
year, accounting for 1.8 million deaths last year. In the United States, these grim 
statistics have shown little improvement in the last decade. Kentucky bears the 
highest lung cancer incidence rate and this outcome is correlated with its top-
ranking smoking rate among the population. Lung cancer is a disease of aging 
and commonly affects people over the age of 60. Currently the five-year survival 
rate of lung cancer is around 16% overall in men and 21% in women according to 
the Center for Disease Control and Prevention and the National Cancer Institute, 
with moderately more favorable outcomes associated with the location of the 
tumor at the time of diagnosis. Data provided by the National Cancer Institute 
and the Surveillance, Epidemiology, and End Results program indicate that 
patients in which their disease is detected early, while the tumor is confined to 
the primary location and has not disseminated to the adjacent lymph nodes have 
a five-year survival rate of approximately 57.4% (Duggan, Anderson, Altekruse, 
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Penberthy, & Sherman, 2016). Once the cancer has spread to adjacent regional 
lymph nodes, this survival rate drops markedly to 30.8%. Tragically, those 
diagnosed with late stage and distant metastatic disease have only a 5.2% 
chance of survival past five years. It is a grim fact that a majority of new patients 
that will be diagnosed with lung cancer, around 80%, will be informed that they 
have regional or distant disease. Metastatic disease is the true killer in lung 
cancer. 
Lung cancer can classically be divided into two types: small cell and non-
small cell lung cancer. While small cell lung cancer is a particularly aggressive 
and devastating disease, with even locally diagnosed tumors rapidly progressing 
and a five-year relative survival rate of just 29%, the biology of small cell lung 
cancer is markedly different than that of non-small cell and will not be discussed 
in this dissertation. Non-small cell lung cancer is also subdivided into several 
histological subtypes including adenocarcinoma, a disease arising from the distal 
glandular epithelial lining of the bronchi, squamous cell carcinoma, arising from 
the more proximal squamous epithelium of the bronchus, and large cell 
carcinoma (Cooper, Lam, O'Toole, & Minna, 2013). Notably, the mean doubling 
time of lung adenocarcinoma and squamous cell carcinoma is around 160 days 
(Arai et al., 1994). This means that from the time of oncogenic transformation 
that results in a tumor cell able to continuously proliferate and evade immune 
detection to the time of a detectable tumor mass by chest radiograph can be over 
a decade. For the vast majority of this time, patients do not experience pain from 
the growing mass and do not experience other related symptoms specific to the 
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disease. Often the first symptoms experienced by the patient are associated with 
metastatic dissemination such as pain associated with tumor invasion into the 
chest wall, liver capsule, or bone structure, or a number of other paraneoplastic 
syndromes. This delays the critical time to diagnosis for the patient, leading to 
poor outcomes, but also allows ample time for mutated cells to adapt and 
modulate a local tumor microenvironment that is conducive to support tumor 
growth, progression, and metastasis. 
The tumor microenvironment of non-small cell lung carcinoma 
The tumor microenvironment of non-small cell lung carcinoma is a 
complex and heterogenous combination of cellular and non-cellular tumor 
promoting elements that exist and coordinate in a dynamic manner to facilitate 
the growth of transformed malignant cells. The cellular constituents include the 
malignant transformed cells themselves and possibly their purported stem-like 
counterparts, vascular endothelial cells, supporting mesenchymal cells such as 
cancer associated fibroblasts and mesenchymal stem cells, and immune cells 
that have been modulated toward a wound healing or immunosuppressive 
phenotype such as macrophages and helper T cells (Quail & Joyce, 2013). The 
non-cellular components include the factors and cytokines that these cells 
produce such as vascular endothelial growth factor (VEGF), transforming growth 
factor beta (TGF-β), hepatocyte growth factor (HGF), and others (Maman & Witz, 
2018). Cancer associate fibroblasts and macrophages are primarily responsible 
for extracellular matrix deposition and facilitate its remodeling respectively 
(Alexander & Cukierman, 2016; Kalluri, 2016). These processes are facilitated by 
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enhanced deposition of extracellular matrix proteins like fibronectin, laminin, 
collagens, and the matrix metalloproteinases (MMP) responsible for degrading 
these structures. This dynamic structural regulation and biochemical modulation 
of the tumor tissue is essential in providing a microenvironment that facilitates the 
transformation of malignant cells and allow further dissemination and survival in 
distal body sites normal differentiated cells are ill-adapted to survive. One such 
purported transformation that may mediate this cellular plasticity and has been 
extensively studied in the context of metastasis is the epithelial to mesenchymal 
transition (EMT) (Soltermann et al., 2008). 
Epithelial to mesenchymal transition 
EMT is a normal process of developing cells within the embryo in which 
cells undergo a transition from an epithelial state characterized by a maintenance 
of cell polarity, cell-to-cell junctions, and cuboidal morphology to a more 
mesenchymal state in which cells lose polarity, gain a more spindle-like 
morphology and an increased migratory capacity, separating from surrounding 
tissue (Lamouille, Xu, & Derynck, 2014). Upon reaching the appropriate location 
or upon stimulus from the environment, the mesenchymal cells are thought to 
undergo the reverse process of mesenchymal to epithelial transition (MET) and 
revert to an epithelial phenotype. However, this phenomenon is not restricted to 
fetal development, as adult somatic cells are implicated to undergo this process 
in a regulated manner in response to organ injury in order to repair damaged 
tissue in a variety of tissues (Stone et al., 2016). However, as tumors have been 
described as “wounds that never heal” (Dvorak, 1986, 2015), this process is 
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hypothesized to be a critical mediator within cancerous tissue to facilitate 
metastasis. 
Driven by certain mutations in oncogenes, epithelial cells undergo 
uncontrolled replication and begin to influence their local environment to respond 
to these wound healing signals, and this response aids in the tumors growth as 
the dysplastic cells undergo additional transformation and the tumor loses normal 
organization and differentiation (Negrini, Gorgoulis, & Halazonetis, 2010). Under 
influence from the microenvironment, these atypical cancerous cells undergo 
EMT to a more mesenchymal phenotype and express MMP in order to penetrate 
the basement membrane of tissue and facilitate migration through the interstitial 
fibers of the ECM to reach nutrients and endothelial lined blood vessels or 
lymphatic vessels. In a process termed intravasation, these cancerous cells 
penetrate through the endothelium in order to reach the bloodstream. A property 
that differentiates epithelial cells from mesenchymal cells is the ability of 
mesenchymal cells to survive anchorage independent growth. Normally, 
epithelial cells that detach from the ECM undergo a process of anchorage 
dependent programmed cell death known as “anoikis” (Paoli, Giannoni, & 
Chiarugi, 2013). In circulation, the mesenchymal-like phenotype of transformed 
cells provides resistance to this form of apoptosis and potentiates survival during 
hematogenous dissemination. Accordingly with Paget’s “seed and soil” 
hypothesis, many transformed cancer cells enter the circulation but only an 
exceedingly small percentage survive and reach to distant metastatic sites, 
where they penetrate the blood vessel by extravasation, and migrate to an area 
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within the pre-metastatic niche with favorable growth conditions (Langley & 
Fidler, 2011; Paget, 1889). Once established, these mesenchymal-like cells 
undergo MET to transition to a more epithelial state, anchor to tissue at a distant 
organ, and begin to respond to local growth factors and proliferate. 
The processes of EMT and MET are also regulated intracellularly and 
extracellularly. Perhaps the most characteristic protein of the epithelial phenotype 
is the cell-cell adherence protein epithelial-cadherin (E-cadherin) (Jeanes, 
Gottardi, & Yap, 2008; Onder et al., 2008). E-cadherin is member of the calcium 
dependent adhesion molecule family of proteins known as cadherins.  Cadherins 
are transmembrane proteins that link cells together through extracellular 
domains, while their intracellular domains bind to β-catenin and serve as linkages 
for several other proteins including α-catenin, p120 catenin, and vinculin to form 
linkages with the actin cytoskeleton in a complex known as the adherens 
junction. The stability of this complex has been demonstrated to be under the 
regulation of kinase activity from receptor tyrosine kinases such as epidermal 
growth factor receptor (EGFR) as well as non-receptor tyrosine kinases such as 
the Src family. For example, Roura et al demonstrated that Src phosphorylation 
of tyrosine 654 of β-catenin reduces the binding affinity for e-cadherin and 
phosphorylation at this site results in disruption of the adherens complex (Roura, 
Miravet, Piedra, Garcia de Herreros, & Dunach, 1999). Additionally, e-cadherin 
expression is tightly regulated and repressed by the Snail family of zinc-finger 
transcription factors including Snail and Slug, the basic helix-loop-helix protein 
Twist, and others. Importantly, aberrant e-cadherin expression and localization is 
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a feature of advanced tumor progression and correlates with increased 
invasiveness of tumors, whereas overexpression of e-cadherin can suppress 
invasion in some cancer cell types. The loss of e-cadherin and cell-to-cell 
contacts is coupled with the expression of neural cadherin (N-cadherin) and other 
proteins such as vimentin, alpha-smooth muscle actin, and fibronectin which are 
associated with a mesenchymal phenotype. The stabilization of this 
mesenchymal state also confers an increased motility to cells to facilitate 
migration of single cells from the primary tumor (Aiello et al., 2018). 
Cell migration and invasion processes in 2D and 3D environments 
Cell migration is a critical component of cancer metastasis. The molecular 
aspects of cell migration have been studied extensively in-vitro predominantly 
using slow moving fibroblasts or rapidly and uniformly motile keratinocytes. 
These experiments have led to a proposed multistep mechanism of migration by 
which cells first establish polarity toward an inducing extracellular stimulus 
creating frontward protruding adhesions at the leading edge and contracting 
adhesions at the rear of the cell in order to propel the cell forward. Next, actin is 
assembled at the leading edge of the cell in various cellular protrusions, each 
with specialized machinery and distinct actin morphologies. One of these 
protrusions, the lamellopodia, is composed of dense, branched actin networks 
under the control of the actin nucleator actin-related protein 2/3 (ARP2/3), 
Wiskott-Aldrich syndrome protein (WASP), WASP-family verprolin homologous 
protein (WAVE), cofilin, and other proteins (Lai et al., 2008; Machesky & Insall, 
1998) that exert a protruding force on the inner surface of the cell membrane in 
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order to extend the cytoplasm forward. Filopodia, another classification of cellular 
protrusion, are composed of parallel aligned actin filaments (F-actin) that extend 
toward the cell membrane with their positive, ATP-bound barbed ends to probe 
the extracellular environment while the negative, ADP-bound pointed ends are 
oriented toward the cell interior (Mattila & Lappalainen, 2008). Adhesive force 
and tension mediated by myosin machinery result in rearward retraction of this 
actin filament and aid in propelling the cell forward. In the last step of migration, 
adhesions at the rear of the cell are disassembled allowing localized detachment 
of the cell body and contractile forces by myosin motor proteins including myosin 
II to generate force to retract the rear of the cell and propel the cell body forward. 
These adhesions are composed of various cell adhesion molecules that 
form, mature, and disassemble rapidly and dynamically. Adhesion formation is 
thought to begin with the formation of the nascent adhesion. These nascent 
adhesions are composed of kindlin-2, α-actinin, vinculin and other proteins that 
loosely attach the cells actin cytoskeleton to the extracellular environment via a 
heterodimer of transmembrane proteins known as integrin receptors (Sun, 
Lambacher, & Fässler, 2014). Integrins bind to several different protein motifs on 
extracellular proteins such as collagen (DGEA), fibronectin, laminin, and 
vitronectin (RGD), and others (Horton et al., 2016). As the focal complex recruits 
additional force sensitive proteins including talin, kindlin-1, and paxillin, more 
integrin pairs are recruited to the adhesion in a process known as clustering, 
creating further binding sites for accessory adhesion proteins such as focal 
adhesion kinase (FAK) and integrin linked kinase (ILK). Force generated by the 
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extracellular integrin linkage and dense bundles of F-actin cytoskeleton known as 
stress fibers assists in the maturation of nascent adhesions to larger signal 
transducing structures known as focal adhesions (Tai, Chen, & Shen, 2015). 
Focal adhesions generate signals through focal adhesion kinase and other 
kinases in order to modulate a wide variety of cell processes including actin 
remodeling, cellular contraction, proliferation, survival, migration, and invasion 
(Fig. 1). In some cases, these focal adhesions can mature further to fibrillar 
adhesions, which lose their force reactive properties and do not bind to actin 
stress fibers. In other cases, focal adhesions are rapidly disassembled in a 
process dependent upon FAK (Geiger & Yamada, 2011; Hamadi, 2005). Thus, 
FAK plays a central role in the dynamic regulation of focal adhesions within cells. 
While the mechanisms of cell migration are fairly well characterized under 
in vitro conditions in which cells are grown on a 2-dimensional (2D) substrate, 
less is known about the migration of cells in-vivo, where cells maintain 
connections through adherens junctions as they migrate in a process termed 
collective cell migration and are surrounded on all sides by extracellular 
substrates including ECM (3D), and these are active areas of research. 
Fibroblasts and cancer cells grown on plates coated with ECM substrates such 
as collagen, fibronectin, or vitronectin exhibit markedly different morphological 
characteristics than those grown on glass or plastic. On surfaces coated with 
fibrillar collagen gels, fibroblasts form adhesions along the fibers of the matrix, 
providing them with an elongated spindle shape with parallel arrangements 
similar to mesenchymal cells embedded within connective tissue in-vivo such as 
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cartilage (P. Friedl & Brocker, 2000). This change in cell structure is 
accompanied by a difference in migratory function as fibroblasts and cancer cells 
grown on 3D substrates alter their cytoskeleton and matrix adhesions to facilitate 
travel through a more complex architecture compared to a flat surface. The first 
of these migratory strategies is termed mesenchymal migration in which cells 
utilize extended cellular projections classified as pseudopodia to form matrix 
adhesions including integrins to anchor to the matrix stabilized with F-actin, 
decrease their velocity, and localize matrix degrading enzymes like MMPs to 
degrade through migratory barriers. In the second form of 3D migration, termed 
amoeboid migration, cells decrease their matrix adhesions, allowing the cell body 
to become more rounded, increase contractile activity to produce membrane 
blebs, and squeeze through structures in an MMP-independent manner similarly 
to the behavior of leukocytes to accomplish high cellular velocities. Cancer cells 
in vitro demonstrate both methodologies of migration and can actively alter their 
migrations strategy, however whether this behavior is dependent upon a cell 
intrinsic regulatory mechanism or is solely a factor of the encountered 
extracellular environment are currently active areas of research. 
Aside from migration, invasion through the basement membrane into 
surrounding structures is a critical parameter for cancer dissemination and 
metastasis, as invasive tumors are characteristic of late stage disease. 
Frequently this step in the metastatic cascade is modeled through the inclusion 
of a basement membrane-like material derived from Englebreth-Holm-Swarm 
mouse sarcoma cells and marketed under the trade name Matrigel. Matrigel 
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contains a number of constituents found in the basement membrane including 
laminins, collagen IV, and entactin, as well as an assortment of growth factors 
and cytokines including EGF, transforming growth factor beta (TGF-β), and 
platelet-derived growth factor (PDGF), although it is also available in a growth 
factor reduced form. Classically, this material is used to coat the upper surface of 
a porous membrane where the gel is polymerized to a thin matrix coating. 
Cancer cells are placed on top of this membrane and the number of cells that 
invade through the matrix and migrate to the opposite side of the membrane are 
quantified at endpoint. To accomplish this task, cancer cells adapt to their 
environment and produce cellular protrusions termed invadopodia. Invadopodia 
are critical structures in cell invasion found in aggressive tumor cells but not 
normal cells. Their assembly can be promoted through EGFR signaling, and the 
cortical actin binding protein cortactin has been found to be necessary for the 
early assembly of an F-actin core within these protrusive structures. Src, 
downstream of EGFR, has been shown to be a critical mediator of invadopodia 
maturation through tyrosine phosphorylation of cortactin and other proteins. The 
mature invadopodia promotes invasion through targeting MMP, particularly MT1-
MMP to the ECM. 
Extracellular matrix and microenvironment characteristics that promote 
metastasis 
Apart from its protein composition, the ECM possesses multiple properties 
that promote transformation and plasticity of a variety of cell types. Alterations of 
the ECM stiffness, linearity, and density are correlated with worse features in a 
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variety of fibrotic pathologies including idiopathic pulmonary fibrosis, liver 
cirrhosis, and chronic kidney disease, as well as cancers including those of the 
breast, pancreas, and others (Biagini & Ballardini, 1989; Cox & Erler, 2011; 
Herrera, Henke, & Bitterman, 2018; Jena & Janjanam, 2018; H. O. Lee et al., 
2011). Fibroblasts and other mesenchymal cells are thought to be primarily 
responsible for the deposition and assembly of the complex array of proteins and 
proteoglycans which compose the ECM, however frequently other cells within the 
microenvironment including epithelial cells and leukocytes also locally organize 
and remodel the ECM, cross-linking proteins like fibronectin with collagen or 
degrading matrix through MMP secretion and activation. The assembly and 
remodeling of the ECM by diseased or desmoplastic tissue can create structures 
that facilitate migration of cells by creating tracks or tunnels, create barriers to 
leukocyte infiltration, modulate stiffness, and provide a reservoir of zymogens or 
matrikines, ECM components that possess binding motifs which can stimulate 
growth factor receptors like EGFR, that can be liberated from the ECM by MMP 
mediated proteolysis. 
Aside from these structural elements, other components of the tumor 
microenvironment play an important role in cancer progression and the regulation 
of processes such as EMT. For example, cancer associated fibroblasts or 
mesenchymal cells (CAM) produce extracellular matrix proteins, but they have 
also been shown to secrete a variety of cytokines and growth factors into the 
tumor microenvironment to facilitate different elements of tumor growth or play a 
role in mediating resistance to chemotherapeutic drugs. During the reciprocal 
13 
 
cross talk between cancer cells and their supportive CAM stroma, the CAM cells 
secrete epidermal growth factor (EGF), hepatocyte growth factor (HGF), and 
insulin-like growth factors (IGF) and others to support tumor growth and 
proliferation. CAM have also been demonstrated to promote angiogenesis in 
tumors through secretion of VEGF and PDGF. Aside from these growth factors, 
in a study by Navab et al., gene ontology analysis of expression profiles from 
cancer associated fibroblasts and matched normal fibroblasts from NSCLC 
patients revealed that enriched genes were associated with associated with 
extracellular proteins and membrane-bound proteins, mostly involved in signal 
transduction, cell adhesion, and response to cell stress (Navab et al., 2011). 
Many of these proteins were also associated with TGF-β regulation, another 
growth factor that is secreted by activated CAM cells. Through these studies and 
others, it has recently been shown that CAM cells are major influencers of cancer 
progression, and understanding the mechanisms that govern the activation and 
aberrant gene expression of these activated cells will be critical to the 
development of treatments in the future. 
One element of the tumor microenvironment important to the regulation of 
gene expression in tumor and stromal compartments is hypoxia. Generally, a 
growing tumor requires a vascular supply in order to transport nutrients to and 
waste from the rapidly dividing cells. The availability of blood supply has been 
shown to be a critical determinant of tumor growth. As the tumor grows, the 
center of the tumor becomes cut off from the blood supply resulting in a gradual 
oxygen deprivation toward the center of the tumor mass resulting in necrosis. To 
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compensate, cells that are undergoing hypoxic and nutrient stress express genes 
in order to promote the recruitment, migration, and proliferation of endothelial 
cells that undergo angiogenesis.  Within the tumor microenvironment there is an 
imbalance of pro- and anti-angiogenic factors, and this may contribute to the 
aberrant vasculature found in tumors characterized by tortuous, dilated and leaky 
vessel walls. Many of these genes are under the control of an oxygen sensitive 
regulator called hypoxia inducible factor 1 alpha (HIF1-α). HIF1-α expression is 
correlated with worse tumor progression and can activate EMT and invasion in 
cancer cells. It can enhance expression of several enzymes involved in post-
translational modification of collagen and can lead to stiffer, aligned ECM fibers 
that can drive tumor progression. HIF1-α can also alter the expression of MMP 
and urokinase plasminogen activator receptor (uPAR), thus hypoxia also plays a 
central role in ECM remodeling (Petrova, Annicchiarico-Petruzzelli, Melino, & 
Amelio, 2018). 
Extracellular matrix remodeling  
ECM remodeling is characterized by a balance of ECM deposition and 
degradation by MMP and other proteases. One of the major proteolytic systems 
important in various fibrotic pathologies is mediated by plasminogen and its 
major regulator plasminogen activator inhibitor-1 (PAI-1). The plasminogen-
plasmin system modulates migration and tissue remodeling by interactions with 
the ECM and by regulating signal transduction (Fig. 2). PAI-1 is a serine protease 
inhibitor and is the main regulator of the plasminogen activation system. PAI-1 
inhibits both tissue-type plasminogen activator (tPA) and urokinase-type 
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plasminogen activator (uPA), decreasing the cleavage of plasminogen to the 
active enzyme plasmin. Aside from fibrin, plasmin can directly degrade ECM 
components such as laminin, proteoglycan, and type IV collagen (Liotta et al., 
1981), inducing matrikine peptides capable of signal transduction, and also 
indirectly degrade ECM via activation of several pro-MMPS to their active form 
including MMP2, MMP3, MMP9, MMP12, and MMP13 (Jaiswal, Varshney, & 
Yadava, 2018) (Ramos-DeSimone et al., 1999). PAI-1 has important biological 
activities that extend beyond its inhibition of ECM degradation. PAI-1 activity and 
expression have been shown to mediate a number of tumorigenic processes 
through its interaction with uPA and other elements of the ECM. PAI-1 exists in 
latent and active forms in plasma. Active PAI-1 is unstable and binds to the ECM 
protein vitronectin to prevent spontaneous conversion to the latent form (Seiffert, 
Mimuro, Schleef, & Loskutoff, 1990). The binding of PAI-1 to vitronectin prevents 
integrins from binding to vitronectin, resulting in inhibition of integrin mediated cell 
adhesion and migration depending on the cell type (Whitley, Palmieri, Twerdi, & 
Church, 2004). However, PAI-1 has also been shown to enhance cell adhesion 
and migration of breast cancer cells (Chazaud et al., 2000; Whitley et al., 2004). 
Further evidence for the ability of PAI-1 to contribute to tumor progression was 
shown by adding PAI-1 to cells in culture. Exogenous PAI-1 was sufficient to 
block spontaneous and induced apoptosis, possibly by upregulating c-Jun/ERK 
and BCLxl, while downregulating BAX expression (Balsara & Ploplis, 2008). 
Interestingly, inhibitors of PAI-1 block cellular migration and invasion in murine 
cancer models, as well as the seeding of lung cancer cells in the lungs of mice, 
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preventing lung cancer metastasis through inhibition of host interactions and 
independently of tumor PAI-1 levels (Masuda et al., 2013). In the clinical setting, 
elevated plasma PAI-1 levels are associated with poor prognosis in cancer 
patients (Look et al., 2002; Pavey, Hawson, & Marsh, 2001). Importantly, 
increased PAI-1 expression in lung cancer patients correlates with cancer 
mortality (Di Bernardo, Matakidou, Eisen, Houlston, & Consortium, 2009; Gemma 
et al., 2001; Pappot, Pedersen, Brunner, & Christensen, 2006; Pappot, Skov, 
Pyke, & Grondahl-Hansen, 1997). Through these mechanisms and others, PAI-1 
has been shown to be involved in cancer development, growth (Jing et al., 2012), 
and metastasis through inhibition of apoptosis (Balsara & Ploplis, 2008), 
increased tumor cell adhesion to endothelium (Prager, Breuss, Steurer, Mihaly, & 
Binder, 2004), proliferation (Y. P. Zhang et al., 2013), and disruption of tumor cell 
interaction with the extracellular matrix (Czekay, Aertgeerts, Curriden, & 
Loskutoff, 2003). These studies highlight the importance of studying the stromal 
and supporting elements of the tumor microenvironment, and particularly ECM 
interactions of cancer cells.  
In-vitro models of the tumor microenvironment 
In order to recapitulate structural elements of the tumor microenvironment, 
researchers have utilized in-vitro strategies that include preparation of collagen 
gels on plastic or glass slides. Variations in the fibrillar structure of these matrices 
can be achieved through changing their preparation parameters including varying 
concentration, temperature, and chemically induced crosslinking of fibers. 
Fibroblasts and cancer cells grown on these fibrillar gels exhibit distinct 
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morphological differences, including extension of long, thin, cellular projections 
termed pseudopodia that extend outward from the cell to connect to the matrix. 
Alterations of the stiffness of the collagen matrix are capable of altering the 
invasive capabilities of cancer cells. MDA-MB 231 breast cancer cells exhibit a 
biphasic invasive response that depends on the concentration, stiffness, and 
porosity of the hydrogel, where they exhibit greater invasive behavior on soft and 
crosslinked matrices and stiff, porous matrices (Lang et al., 2015). While these 
constructs are useful in studying cell-matrix interactions, they may be insufficient 
in recapitulating some of the ECM alterations associated with the tumor 
microenvironment. For example, when collagen gels are combined with Matrigel, 
H1299 lung cancer cells alter their morphology and migration characteristics 
(Anguiano et al., 2017). In a collagen hydrogel, the cells adopted a mesenchymal 
migration phenotype with polarization of the cell body and lamellipodia adhesions 
at the front and rear of the cell. In the combined collagen and Matrigel matrix, the 
cells shifted to short, blunted lobopodia protrusions to navigate the matrix, and 
the maintenance of this mesenchymal phenotype required β1 and β3 integrin 
matrix adhesion. In contrast to single or dual ECM component approaches, an 
alternative method to produce ECM is directly from cell culture of the main ECM 
producing cells in the body, the fibroblast. Cultured at confluence, and supported 
with supplements of ascorbic acid to promote collagen deposition and 
crosslinking over the course of a week or more, fibroblasts and other 
mesenchymal cells produce an ECM that contains protein constituents found in 
tissue, and is organized and cross-linked by depositing cells to recapitulate the in 
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vivo microenvironment. These culture plates are then denuded of cells using 
methods which preserve the structural and biochemical components of the ECM 
and are then carefully washed and treated with DNA digesting enzymes to 
remove nuclear debris from the glycosylated matrix. Following cell extraction, the 
cell derived ECM constructs are used as scaffolds for cells to study cell-matrix 
interactions and downstream behaviors. In a landmark study, Cukierman et al. 
demonstrated that 3T3 mouse embryonic fibroblasts (MEF) attach to 2D 
fibronectin differently than fibroblasts attach to the ECM in vivo, and that these 
cell-matrix adhesions could be recapitulated when fibroblasts were grown on a 
fibroblast-derived ECM. These matrix adhesions were characterized with triple 
localization of α5 integrin, paxillin, and fibronectin (Cukierman, Pankov, Stevens, 
& Yamada, 2001). Other components of these matrix adhesions included α-
actinin, F-actin, talin, tensin, and vinculin, however these components were 
shared by focal and fibrillar adhesions. 
This work served as a catalyst for investigators to use this system to study 
cell-matrix adhesions and ECM dependent cell signaling and behavior in a 
variety of contexts, including vasculogenesis (Soucy, Hoh, Heinz, Hoh, & Romer, 
2015), stem cell differentiation (X. D. Chen, Dusevich, Feng, Manolagas, & Jilka, 
2007), and cancer biology (Scherzer et al., 2015). Soucy et al. used 
immunofluorescence microscopy to characterize a lung fibroblast derived ECM to 
contain fibronectin, tenascin-C, collagen I, collagen IV, and collagen IV, among 
others (Soucy & Romer, 2009). While many of these proteins colocalized, 
fibronectin had a more unique distribution. Human umbilical vein endothelial cells 
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(HUVEC) grown on these lung fibroblast derived ECM were found to have cell 
matrix adhesions containing β1 integrin, phospho-tyrosine 397 FAK, phospho-
tyrosine 410 p130Cas, vinculin, and talin. Additionally, these matrix adhesions 
localized with MT1-MMP, suggesting an association with invadopodia formation. 
Remarkably, HUVEC grown on lung fibroblast ECM formed tubular networks 
after 24 hours, demonstrating the benefits of physiologically relevant cell culture 
systems on tubulogenesis. 
Previously in our lab, Scherzer et al extended this lung fibroblast derived 
ECM to study the interaction of lung adenocarcinoma cells with the extracellular 
matrix (Scherzer et al., 2015). Among the findings of that study were marked 
differences in cell morphology of A549 to an elongated appearance, resistance to 
serum withdrawal and chemically induced hypoxia, increased migration velocity 
and directionality, and a decrease in E-cadherin expression. The characterization 
of this model in the context of lung cancer allows us to now ask questions related 
to lung cancer cell metastatic processes in a physiologically relevant manner. For 
example, what signaling mechanisms are induced by cell-matrix interactions with 
a lung fibroblast deposited extracellular matrix? What are the cellular 
components of these interactions and what ligands do they interact with 
extracellularly? What characteristics of cell migration are promoted by 
extracellular matrix interactions in the tumor microenvironment and are there 
specific signaling mechanisms we could target to inhibit 3D migration? What role 
does extracellular matrix remodeling play in the context of NSCLC? Would an in-
vitro physiological microenvironment promote alterations in extracellular matrix 
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deposition, and would these altered matrices differentially affect cancer cells or 
cancer activated fibroblasts? Does a microenvironment that contains the 
extracellular matrix and physiological hypoxia preserve characteristics of lung 
tumors found in-vivo? Are the cancer associated stromal elements able to 
influence cancer progression through extracellular matrix deposition?  
To begin to answer these questions, we formed the hypothesis that a 
microenvironment mimetic in-vitro culture system consisting of a lung cell-derived 
extracellular matrix and a physiological oxygen environment would preserve and 
promote in-vivo tumor characteristics and modulate migration and invasion of 





Determine how ECM interactions with lung adenocarcinoma cells can 
promote hallmarks of cancer metastasis in a physiologically relevant in vitro 
model. 
Overall hypothesis 
A microenvironment mimetic in-vitro culture system consisting of a lung 
cell-derived extracellular matrix and a physiological oxygen environment would 
preserve and promote in-vivo tumor characteristics and modulate migration and 
invasion of lung adenocarcinoma cells through cell-matrix interactions. 
SPECIFIC AIMS 
1. Investigate the mechanism and modality of 3D migration of lung 
adenocarcinoma cells on extracellular matrix. 
2. Determine the effect of physiological hypoxia and extracellular 
matrix on tumor stroma. 















Figure 1. Cell-matrix interactions in cancer cells promote cellular processes involved in 
metastasis.  
Interactions with extracellular matrix through integrins activate multiple signaling cascades 
independently and through crosstalk with growth factor receptors to affect survival, cell 
adhesion, cytoskeletal remodeling, proliferation, migration, and adhesion. Matrix 
metalloproteinases released from the cell mediate pericellular remodeling of the ECM by 
degrading ECM proteins and activate latent growth factors within the microenvironment. These 
factors and the matrix peptides further potentiate cell surface receptor signaling. This figure 






Figure 2. Plasminogen activator inhibitor 1 (PAI-1) regulates pericellular proteolysis and 
cell migration.  
PAI-1 regulates ECM degradation and fibrinolysis directly by inhibiting the catalytic activation 
of plasminogen, which is localized to the cell surface by Annexin A2 and S100A10 or embedded 
within fibrin clots, to the active enzyme plasmin by either tissue-type plasminogen activator 
(tPA) or urokinase-type plasminogen activator (uPA) and its receptor (uPAR). Plasmin 
degrades extracellular matrix substrates and activates pro-forms of matrix metalloproteinases 
(Pro-MMP) to their active state (MMP). The uPA/uPAR complex also associates with integrins 
to induce intracellular signaling through Jak/STAT, FAK, PI3K, and other pathways. Vitronectin, 
an ECM protein, has binding sites for PAI-1 and uPAR, however PAI-1 binds with higher affinity 
and can prevent association with the receptor. PAI-1/uPAR complexes are internalized within 
the cell, where the PAI-1 is targeted for lysosomal degradation and uPAR is recycled to the cell 
surface to facilitate attachment and migration of the cell. PAI-1 also interacts with intracellular 
substrates such as caspase 3 to inhibit apoptosis, and may be involved with other intracellular 




CHAPTER II: MATERIALS AND METHODS 
Human tissue samples 
Primary human lung cancer resections (six) were acquired and de-identified from 
patients undergoing resection of pulmonary tumors without preoperative 
chemotherapy or radiotherapy at the James Graham Brown Cancer Center at the 
University of Louisville. Patients with lung adenocarcinoma and squamous cell 
carcinoma were staged according to the tumor-node-metastasis system 
established by the American Joint Committee on Cancer. This study was 
approved by the IRB committee of the University of Louisville (#130188) and 
informed consent was obtained from all patients. All experiments were performed 
in accordance with relevant guidelines and regulations. 
Hypoxic cell culture 
Hypoxic cell culture conditions (5% O2, 5% CO2, 90% N2, 37ºC) were achieved 
with a modified water jacketed cell culture incubator equipped with a ProOx P110 
oxygen controller (BioSpherix, Parish, NY). The sensor was calibrated and 
programmed to maintain a setpoint of 5% O2 via infusion of Ultra High Purity 
Nitrogen gas unless otherwise stated. 
Patient sample processing 
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Tumor resections were transported on ice, transferred to a sterile 100 mm cell 
culture plate in ice-cold PBS, imaged and placed in a sterile laminar flow hood. 
The tissue was diced to approximately 1mm3 pieces. The diced tissue was 
transferred to a vial containing collagenase/dispase (Sigma, St. Louis, MO) 
dissolved (1mg/mL) in serum free Dulbecco’s modified Eagle’s medium-high 
glucose (DMEM) for enzymatic digestion. The vial was warmed to 37º C and 
incubated with rocking for at least 1 h 15 m. The tissue suspension was agitated 
with vigorous pipetting to confirm tissue dissociation and either returned to 37º C 
if incomplete or inactivated. Cell suspensions passed through a 70 µM cell 
strainer. A syringe plunger was used to force remaining tissue through the 
strainer and the strainer washed with ice cold PBS. The tissue suspension was 
cooled to 4ºC and then placed in a centrifuge for 3 minutes at 400 cfg and 4ºC. 
The supernatant was aspirated and the cell pellet suspended in growth medium 
(DMEM 2% FBS, Pen/Strep, Cipro). Cell and viability counts were obtained with 
a TC20 automated cell counter (Bio-rad), and cells were placed onto a plate 
coated with human cell derived extracellular matrix and maintained in a climate-
controlled incubator at 37ºC, 5% CO2, and 5% O2 (Fig. 14A). Cells were 
monitored for attachment and healthy morphology at 24 hours post culture and 
the media was changed 4 or 7 days post culture depending on cell attachment. 
Cell culture 
Human normal fetal lung fibroblast cell lines WI38 and IMR90 were purchased 
from American Type Culture Collection (ATCC) and maintained in Minimum 
Essential Medium Alpha modification (MEM-α) supplemented with L-Gln, ribo- 
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and deoxyribonucleosides (Fisher),10% fetal bovine serum (Invitrogen) and 1% 
antibiotic/antimycotic (Sigma). Human bone marrow mesenchymal stem cells 
(hMSC) were purchased from Lonza and cultured as the fetal lung fibroblast cell 
lines. Human embryonic stem cell line H1(WiCell, Madison, WI) was cultured on 
human embryonic stem cell‐qualified Matrigel‐coated plates (BD Biosciences, 
San Jose, CA) in mTeSR1 media (STEMCELL Technologies, Vancouver, 
Canada), with media changed daily. All assays involving comparisons between 
tumor derived stromal cell lines (927, 955, 956, 959, 960, and 1072) and 
mesenchymal cell lines (WI38, IMR90, and hMSC) were performed with early 
passage cells (p < 8) in the same culturing medium, MEMα, described 
previously. A549, H2009, and H2030 human adenocarcinoma cells were 
purchased from ATCC and were cultured in RPMI medium supplemented with 
10% FBS, and 1% antibiotic/antimycotic. A549 NucLight Red human 
adenocarcinoma cells (Essen Bioscience) were cultured similarly, and media was 
supplemented with 1 µg/mL puromycin. All cell lines were maintained at 37ºC 
and 5% CO2, unless otherwise stated. 
Extracellular Matrix Preparation 
Extracellular matrix preparation was performed as previously described(Scherzer 
et al., 2015). Briefly, IMR90 or WI38 fetal lung fibroblasts, or patient derived 
mesenchymal cells, were plated at confluence in matrix growth medium (MEM-α, 
10% FBS, 1% antibiotic). On the second, fourth, and sixth days, medium was 
supplemented with 50 µg/mL L-Ascorbic acid (Sigma) to promote matrix 
deposition. On the eighth day, wells were washed with phosphate buffered saline 
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(PBS) and cells were lysed with a detergent (20mM NH4OH, 0.5% Triton-X-100) 
for 1-3 minute incubation at 37º C until complete cell lysis was observed. 
Resulting cell derived matrices were gently washed three times with PBS, and 
then incubated with Dnase1 (10 U/mL) for 30 minutes to remove residual DNA. 
The matrices were then washed twice in PBS, and either used immediately or 
stored at 4ºC in PBS supplemented with 1% antibiotic for up to 4 months. 
Microscopy and immunocytochemistry 
Phase microscopy images were obtained using a Zeiss AX10 inverted 
microscope. A549, H1, and patient derived cells were fixed with 2% PFA/PBS 
(10 minutes, 24ºC; Electron Microscopy Sciences, Hatfield, PA), permeabilized 
when needed with 0.05% Triton X-100/PBS (5 minutes, 24ºC; Sigma Aldrich, St. 
Louis, MO), and blocked with 5% normal goat serum/PBS (Sigma-Aldrich, St. 
Louis, MO). Cells were probed with mouse monoclonal antibodies recognizing 
SSEA-4 (1:200, ThermoFisher, Walton, MA) and CD90 (PE) (1:200, BD 
Biosciences, San Diego, CA) overnight at 4ºC. Cells were washed with PBS and 
incubated with goat anti-mouse 488 (1:1000, ThermoFisher, Walton, MA). DAPI 
nuclear stain (1:2000; ThermoFisher, Walton, MA) was added (5 minutes, 24ºC), 
washed, mounted, and imaged using Olympus IX81 fluorescence microscope 
(Center Valley, PA). Live cell time-lapse phase and fluorescence microscopy was 
performed using a Cytation 5 Cell Imaging Multi-mode reader (BioTek). 
Immunofluorescent images of co-culture experiments with red nuclear A549 were 
acquired with a Nikon Eclipse Ti microscope with a 4X objective using NIS-
Elements AR acquisition software (Nikon Instruments, Inc., Melville, NY, USA). 
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Nuclear counts from equal image thresholds were quantified automatically using 
the NIS-Elements AR software. 
Cell Proliferation, CFU-F, and Co-culture 
Doubling time experiments were performed by plating approximately 4x104 cells 
in technical duplicates. Mean cell counts were collected at 24 and 96 hours while 
cells were in log phase growth counting at least 100 cells in a hemocytometer. 
Doubling time was calculated using the formula DT=T ln2/ln(Xe/Xb), where T is 
the incubation time, Xb is the cell number at 24 hours, and Xe is the cell number 
at 96 hours. CFU-F assay was performed by seeding 50 cells in a 35-mm well. 
Media was refreshed on days 7 and 10. Colonies were fixed in methanol and 
acetic acid (7:1) on days 14-18 and were stained with crystal violet. Greater than 
32 cells were considered colonies. For co-culture studies, stromal cells that had 
grown in 3DH (Fig 14A.) were seeded at confluence density on 35mm glass 
bottom tissue culture dishes (MatTek) to produce monolayers. After 4 days 
growth, 1.5x104 Red A549 cells were seeded onto stromal monolayers and 
maintained in RPMI (10% FBS, 1% antibiotic/antimycotic) and monitored daily. 
Migration and Invasion 
Lung cancer cells were plated at confluence and serum starved overnight 
following attachment. A micropipette tip was used to create a scratch in the cell 
monolayer and pictures were captured at the indicated time points. 3D invasion 
assays were plated using a WI38 derived matrix that had not been supplemented 
with ascorbic acid during the growth. Ascorbic acid supplementation or use of 
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IMR90 fibroblast matrices results in a matrix that was too thick to reliably scratch. 
Invasion assays utilized a layer of Matrigel containing either vehicle or drugs after 
the scratch had been made. Images were captured at the indicated timepoints 
and results were quantified using the area measurement of imageJ, comparing 
the wound closure at the time of the image to the initial wound. Averages of at 
least three images were captured for each time point and at least two replicates 
were used for each individual experiment.  
Spheroid Preparation 
Lung cancer cells were culture under normal conditions on a Corning ultralow 
attachment 96 well plate (Sigma) at 1x104 cells per well for a period of 6 days to 
allow small, rounded spheroids. Spheroids were observed under microscopy and 
transferred to matrix plates with a micropipette for further migration studies. 
Generation of Human PAI-1 by LentiCRISPRv2 
SERPINE1 (PAI-1) -/- cell lines were generated using CRISPR-Cas9 mediated 
genome editing as previously described (Shalem et al., 2014). Briefly, we used 
selected two guide RNA sequences that targeted the first and second exons of 
the SERPINE1 gene. Complimentary oligonucleotides containing the shRNA 
sequences (Guide 2: 5’-CACCGAACCACGTTGCGGTCCTTGG-3’; guide 3: 5’- 
CACCGCTGGACGAAGATCGCGTCTG-3’) were digested by BsmBI and cloned 
into the lentiCRISPR v2 plasmid (Addgene #52961). Lentivirus was generated 
using 293T cells transfected with 6 µg lentiCRISPR v2 or pLX304 containing 
SERPINE1 cDNA (DNASU HsCD00440510) plasmids, 3 µg psPAX2, and 1.5 µg 
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pMD2.G in optiMEM with a 3:1 ratio of polyethylenimine (PEI) to total DNA. 
Lentivirus was collected 48 hours after transfection, twice daily over a two-day 
period, and filtered in a 0.22 µm filter. A549, H2030, H2009, and IMR90 cells 
were infected twice with lentivirus over a 48 hour period and then selected with 
puromycin or blasticidin (for pLX304; 2-50 µg/mL) containing media (0.5-1.5 
µg/mL). Single clones were generated by plating low densities of puromycin 
resistant cells and isolating single colonies with cloning cylinders after 10-14 
days of colony growth. Cell lines were maintained in 0.5 µg/mL puromycin 
containing media after selection. 
Western Blot 
Cells and tissue samples were harvested in CHAPS lysis buffer (1% CHAPS 
detergent, 150mM NaCl, 50mM Tris pH7, 5mM EDTA) supplemented with 
cOmplete protease inhibitor and PhosSTOP phosphatase inhibitor cocktail 
tablets (Sigma-Aldrich, St. Louis, MO). Tissue samples were homogenized in a 
mini-bead beater. Protein was quantified by using Pierce’s BCA Protein Assay 
Reagent Kit (ThermoFisher, Walton, MA) as per the manufacturer’s instructions. 
Total protein (20µg) was heated at 95ºC for 5 minutes and separated by 4-12% 
SDS-polyacrylamide gel. Blots were transferred to PVDF membranes for 120 
minutes at a constant voltage of 100 V in 4ºC. Membranes were blocked in 5% 
milk (w/v) in Tris-buffered saline Tween-20 (TBS-T) at 24ºC for 1 hour. The 
membranes were incubated with primary antibody in 5% milk TBS-T overnight at 





Antibody Host Catalog Distributor 
HIF-1α (D2U3T) Rabbit #14179 Cell Signaling Technologies 
p21 Waf1/Cip1 (12D1) Rabbit #2947 Cell Signaling Technologies 
α-Smooth Muscle Actin Rabbit #14968 Cell Signaling Technologies 
Src  Rabbit #2108 Cell Signaling Technologies 
P-Src Family (Tyr416) Rabbit #2101 Cell Signaling Technologies 
P-Paxillin (Tyr118)  Rabbit #2541 Cell Signaling Technologies 
Vimentin (D21H3) Rabbit #5741 Cell Signaling Technologies 
N-Cadherin  Rabbit #4061 Cell Signaling Technologies 
Slug (C19G7)  Rabbit #9585 Cell Signaling Technologies 
Snail (C15D3)  Rabbit #3879 Cell Signaling Technologies 
EGF Receptor (D38B1)  Rabbit #4267 Cell Signaling Technologies 
P-EGFR(Tyr1068) Rabbit #3777 Cell Signaling Technologies 
Akt (pan) (C67E7)  Rabbit #4691 Cell Signaling Technologies 
P-Akt (Ser473) (D9E)  Rabbit #4060 Cell Signaling Technologies 
p38 MAPK (D13E1)  Rabbit #8690 Cell Signaling Technologies 
P-p38 MAPK 
(Thr180/Tyr182) (D3F9)  
Rabbit #4511 Cell Signaling Technologies 
PAI-1 Mouse #612024 BD Transduction Labs 
Zeb1 Rabbit #05987 Novus biologicals 
E-Cadherin (24E10) Rabbit #3195 Cell Signaling Technologies 
TGF-β Rabbit #3711 Cell Signaling Technologies 
LC3B (D11)  Rabbit #3868 Cell Signaling Technologies 
Basic Cytokeratin (AE3) Mouse #57004 Santa Cruz 







Antibody Host Catalog Distributor 
p44/42 MAPK (Erk1/2)  Rabbit #4695 Cell Signaling Technologies 
Phospho-p44/42 MAPK 
(Erk1/2) (Thr202/Tyr204) 
Rabbit #4370 Cell Signaling Technologies 
Annexin II (C-10) Mouse #28385 Santa Cruz 
p-Annexin II (85.Tyr 24) Mouse #135753 Santa Cruz 
PAI-2  Mouse #166539 Santa Cruz 
Plasminogen Mouse #376324 Santa Cruz 
Integrin αV Rabbit #4711 Cell Signaling Technologies 
Integrin β3  Rabbit #4702 Cell Signaling Technologies 
P-Stat3 (Tyr705)  Rabbit #9131 Cell Signaling Technologies 
FAK (D2R2E) Rabbit #13009 Cell Signaling Technologies 
P-FAK (Tyr397) (D20B1)  Rabbit #8556 Cell Signaling Technologies 
P-FAK (Tyr576/577) Rabbit #3281 Cell Signaling Technologies 
P-FAK (Tyr925)  Rabbit #3284 Cell Signaling Technologies 
RhoA (67B9)  Rabbit #2117 Cell Signaling Technologies 
ILK1 (4G9) Rabbit #3856 Cell Signaling Technologies 
GAPDH (D16H11)  Rabbit #5174 Cell Signaling Technologies 
β-Actin Mouse #A2228 Sigma 
Rabbit IgG HRP Goat #7074 Cell Signaling Technologies 
Mouse IgG HRP Horse #7076 Cell Signaling Technologies 




Cultures of A549, hMSC, and patient sample cell lines were collected with trypsin 
and washed with PBS. Cells were blocked for 15 min at 4ºC with Fc Block 
(#553142, BD Biosciences, Miami, FL, USA). The samples were then stained 
with a mix of fluorophore-conjugated anti-human monoclonal antibodies: FITC 
CD90 (Thy1), PE CD105, and PerCP/Cy5.5 CD73 (Ecto-5'-nucleotidase) from 
BioLegend (San Diego, CA) for 1 h at 4ºC. Stained cells were then examined on 
a Becton Dickinson FACScan with FlowJo analysis software. 
RT-qPCR 
Total RNA from cell culture samples was isolated with E.Z.N.A Total RNA Kit 
(Omega), according to the manufacturer’s instructions. Total RNA (350 ng) was 
then DNase digested with TURBO DNA-free kit (Invitrogen) per the 
manufacturer’s instructions. DNase digested RNA was then reverse transcribed 
using High Capacity cDNA Reverse Transcription Kit (ThermoFisher, Walton, 
MA). Gene-specific cDNA was quantified with real-time RT-PCR using self-
designed SYBR assays. Primers for qPCR were manually designed with Primer 
Express 3.0 software (Applied Biosystems, Foster City, CA) per the 
manufacturer’s instructions for SYBR green dye assays.  RT-qPCR was 
performed with iTaq Universal Sybr Green Supermix (Bio-Rad). Expression 
levels were analyzed using ΔΔCT method and were normalized to β2-
microglobulin (B2M) mRNA levels. PCR reactions were analyzed on a BioRad 





NRG (NOD/RAG1/2(-/-) IL2Rγ(-/-), #007799) mice were purchased from the 
Jackson Laboratory and animal procedures were approved by the institutional 
animal care and use committee under IACUC #18214 and all experiments were 
performed in accordance with relevant guidelines and regulations. 2.5x106 
IMR90, hMSC, 955, and 959 stromal cells were subcutaneously injected alone 
(N=3) or co-injected with 5x105 Red A549 (N=8) bilaterally into the flanks of NRG 
mice. Mice were euthanized after 30 days and tumors and lungs were resected 
from mice. Tissues were fixed in 10% buffered formalin phosphate and paraffin 
embedded. Tissue sections were stained with H&E. 
Gene Forward Reverse 
ZFP42 (REX-1) TTTGAGTCCTTGGAATACCTAAAGAAA AATTCTCTCCAACTATCTTTTGTGGAA 
TNC (Tenascin C GAGAACAAGAAGAGCATTCCTGTCA GGACTTGAATTTCAGGCCTTCA 
POSTN (Periostin) TGGTTATATGAGAATGGAAGGAATGA GTCAGAATAGCGCTGCGTTGT 
NANOG GAACCTCAGCTACAAACAGGTGAA TTTCTGCCACCTCTTAGATTTCATT 
POU5F1 (Oct4) CCAAGCTCCTGAAGCAGAAGA TTGGCTGAATACCTTCCCAAA 
SOX2 GCACAACTCGGAGATCAGCA TCTCCGTCTCCGACAAAAGTTT 
CPSG4 (NG2) CACTGTCCTGCCTGTCAATGA CCGTCCGTGCTCCTCAGA 
VEGFA CTTGCTGCTCTACCTCCACCAT GACATCCATGAACTTCACCACTTC 
SERPINE1 (PAI-1) TGAAGATCGAGGTGAACGAGAGT GCTGAGACTATGACAGCTGTGGAT 
B2M TGACTTTGTCACAGCCCAAGATA AATGCGGCATCTTCAAACCT 




Student’s t-tests were used for comparisons between two groups. A one-way 
ANOVA with Tukey’s test for multiple comparison were used to determine 
statistical significance for multiple groups, unless otherwise stated. Statistical 




CHAPTER III: INTEGRIN SIGNALING THROUGH CELL MATRIX 
ADHESIONS PROMOTE MESENCHYMAL MIGRATION AND 
COLLECTIVE INVASION OF LUNG CARCINOMA CELLS ON CELL-
DERIVED ECM 
INTRODUCTION 
The extracellular matrix (ECM) is a highly dynamic component of the 
tumor microenvironment that dictates the structure and organization of cellular 
and tissue elements through providing structural scaffolding and access to 
bioactive molecules that mediate tissue growth and differentiation (Burgstaller et 
al., 2017; Frantz, Stewart, & Weaver, 2010). The ECM and associated structures, 
termed the matrisome, of the lung are composed of a diverse array of proteins 
and glycoproteins, such as collagen, elastin, fibronectin, vitronectin, laminin, 
osteopontin and others, as well as proteoglycans including perlecan and the 
hyalectins decorin, versican, and lumican (Yue, 2014). These protein 
components provide much of the tensile and elastic strength of the pulmonary 
architecture, while hydrophilic proteoglycans bind to growth factors within the 
microenvironment including transforming growth factor beta 1 (Kolb, Margetts, 
Sime, & Gauldie, 2001). Both components serve as mediators of cell matrix 
interactions.  Although the ECM is thought to be mainly deposited by stromal 
elements of the tumor microenvironment including cancer activated fibroblasts 
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(CAF) or mesenchymal (CAM) cells, cancer cells are also able to interact with 
and modify the ECM (B. Lee, Konen, Wilkinson, Marcus, & Jiang, 2017; 
Malandrino, Mak, Kamm, & Moeendarbary, 2018).  
Cells interact with the various components of the ECM through a variety of 
cell surface adhesion molecules including integrins and other glycoprotein 
families of selectins, syndecans, the hyaluronic acid receptor CD44, as well as 
the integrin associated molecule CD47. Integrins are transmembrane proteins 
thought to be the major receptors involved in linking the actin cytoskeleton of the 
cell to the extracellular matrix. These low affinity receptors exist as noncovalently 
linked heterodimers of subunits α or β of which 18 α subunits and 8 β subunits 
combine to form 24 integrins. Each of these integrins contains an N-terminal 
globular head region that determines its extracellular ligand specificity, a 
transmembrane region, and a short C-terminal cytoplasmic tail which mediates 
interactions with intracellular cytoskeletal scaffolding proteins (C. Smith, 2008). 
These integrins can be grouped according to their ligand specificity with some 
dimers acting as receptors for laminin, collagen, or the Arginylglycylaspartic acid 
motif (RGD) found in many ECM proteins including fibronectin, vitronectin, and 
osteopontin. Upon binding to their extracellular substrates, several scaffolding 
proteins assemble along the integrin cytoplasmic tail including vinculin, paxillin, 
the mechanosensing protein talin, the signaling protein focal adhesion kinase 
(FAK), and dozens of others (Horton et al., 2016). These integrin mediated cell-
matrix structures are dynamic and rapidly assembled to form nascent adhesions 
which mature to focal adhesions and fibrillar adhesions. During this process of 
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assembly and disassembly, FAK is a major mediator of kinase activity that 
regulates many signaling pathways that in turn affect multiple aspects of cell 
behavior including survival, proliferation, migration, and invasion (Appeddu, 
1996; Schaller, 2010). Importantly, activation of FAK results promotes the 
association and stable activation of Src family kinases to promote cell motility, 
proteolytic activity, and invasion, and this function is activated in the tumor 
microenvironment (Mitra, Lim, Chi, & Schlaepfer, 2006). Importantly, these cell 
behaviors are associated with metastasis and epithelial to mesenchymal 
transition (EMT) in cancer. 
Recently, research interests focusing on cell-matrix interactions have 
utilized an in-vitro model that recapitulates the diverse physiology of the ECM 
found in different tissues by using three-dimensional (3D) fibroblast cell-derived 
ECM (CDM) for tissue culture (Cukierman et al., 2001; Yamada & Cukierman, 
2007). Fibroblasts and other cells grown on these 3D CDM exhibit different 
properties compared to traditional culture on plastic or 2D ECM protein coated 
surfaces, but closely resemble structures and behaviors found in-vivo (Soucy et 
al., 2015). Interestingly, a common feature of the cell-matrix adhesions on 3D 
CDM is that they contain integrin, FAK, and paxillin, which colocalized to the 
ECM protein fibronectin (Cukierman, Pankov, & Yamada, 2002; Soucy & Romer, 
2009). Our lab, and others, have shown that cancer cells also alter their 
phenotype when grown in 3D collagen matrices (P. Friedl & Alexander, 2011) or 
on 3D CDM (Scherzer et al., 2015). In particular, the characteristics of single cell 
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migration are vastly altered in 3D and in-vivo environments compared to 2D in-
vitro culture (Fraley et al., 2010; Scherzer et al., 2015). 
However, the mechanisms of altered cancer cell migration on these 3D 
CDM environments are not completely understood in lung cancer, and many 
questions remain. Is collective migration, the behavior of multicellular complexes 
maintaining cell to cell contact and migrating as a unit, altered on 3D CDM? What 
role does cell-matrix adhesion signaling play in mediating migration and invasion 
on 3D CDM and are these pathways similar to 2D signaling? Does culture in a 
physiological in-vitro microenvironment alter the invasiveness and EMT 
characteristics of lung cancer, and what role does cell-matrix adhesion signaling 
play in regulating these phenotypes?  To answer these questions, we utilized a 
microenvironmental culture system that would recapitulate some elements of the 
tumor microenvironment including a lung fibroblast 3D CDM as well as 
physiological hypoxia. We hypothesized that within this system, 3D cell-matrix 
adhesions to the ECM mediate migration, invasion, and EMT of lung cancer cells 





Collective migration patterns of lung cancer cells on cell-derived matrix are 
distinct from 2D and dependent on focal adhesion signaling. 
 Previously in our lab, Scherzer et al. reported that single cell migration 
velocity and directionality of lung carcinoma and epithelial cells are increased 
when interacting with a lung fibroblast derived ECM (Scherzer et al., 2015). 
However, a characteristic of invasive solid carcinomas in vivo is that they 
maintain cell-cell adhesions and migrate collectively to invade tissue (P. Friedl, 
Locker, Sahai, & Segall, 2012). To understand the biology of collective cell 
migration of lung cancer cells, we attempted a variety of models utilizing the cell-
derived matrix (CDM). 
First, we used ultralow attachment plates in order to prepare spheroids of the 
lung adenocarcinoma cell line H2030. H2030 originally was derived from a lymph 
node of a patient with metastatic lung cancer and this cell line is highly motile. 
We transferred these spheroids to either a collagen coated tissue culture plastic 
plate (2D), or to a plate coated with CDM from WI38 fetal lung fibroblasts. These 
plates were then monitored under time lapse microscopy (Fig. 3) for a 48 hour 
period. Videos obtained from these experiments highlight the dynamic nature 
with which cells interact with their substrates. Interestingly, we observed that the 
cells migrating from the spheroid on the 2D surface appeared to spread more 
rapidly than those on the 3D CDM (Fig. 3A) and covered a greater overall area. 
As these results are different than we observed from single cell migration studies, 
this highlights the importance of studying the cell-cell adhesion forces that can 
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promote migration in a collective manner. We also observed that while cells 
migrating from the spheroid on 2D travelled relatively linearly from their point of 
origin away from the spheroid, upon interacting with the matrix some cells 
appeared to change directing while attached cells followed closely behind. This 
polarity was much more obvious on the CDM environment, suggesting a 
microenvironmental control of “leader” cells and “follower” cells characteristic of 
collective cell migration (Peter Friedl & Gilmour, 2009). Additionally, at later 
timepoints we observed dozens of cells streaming and breaking away from the 
migrating mass on 3D but not on 2D, suggesting the ECM also plays a role in 
dictating the transition from collective to single cell migration.  
Further analysis of the tracked individual cells showed that cells interacted 
with the matrix and oriented their direction to a specific direction on the ECM, 
revealing an anisotropic velocity (Fig. 3B). Higher magnification of the early 
timepoints of the videos showed that while cells migrating on 2D possessed 
broad, flat lamellopodia projections with rapidly assembling and disassembling 
adhesions at the leading edge of the cell, cells migrating on 3D extended longer, 
thinner, and more durable protrusions to sense the matrix before migration 
occurred (Fig. 3C). These structures resemble the extended cellular projections, 
tipped with lamellopodia, employed by fibroblasts to navigate a 3D environment 
(Petrie & Yamada, 2012). These structures are known to contain integrins in their 
focal contacts, so we asked the question of whether inhibition of integrin 
signaling would inhibit migration on 3D CDM. 
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 During “outside-in” integrin signaling, integrin α and β heterodimers join 
and attach to an extracellular ligand. This initiates a focal contact between the 
extracellular matrix and the cell which begins to associate intracellular machinery 
to strengthen the complex. Major components of this complex are talin, which 
binds to the cytoplasmic tail of the β integrin subunit as well as actin, and focal 
adhesion kinase (FAK), a major focal adhesion scaffolding protein that has 
intrinsic kinase activity and auto-phosphorylates itself upon formation of a focal 
contact. Phosphorylation of FAK at Tyr 397 induces a conformational shift that 
allows interaction with the SH2 domains of Src family kinases and 
phosphatidylinositol 3-kinase (PI3K). Further phosphorylation of FAK by Src at 
Tyr 925 promotes association the adaptor protein Grb2 (Appeddu, 1996). 
Ultimately, FAK interacts with dozens of proteins involved in signal activation and 
transduction including paxillin, Arp2/3, and p190RhoGEF (Schaller, 2010). FAK 
overexpression is correlated with worse prognosis in breast (Golubovskaya et al., 
2009), and head and neck squamous cell carcinoma (Canel, 2006; Miyazaki et 
al., 2003), and has been found to be overexpressed in many other cancers 
(Yoon, Dehart, Murphy, & Lim, 2015). Given the relevance of integrin, FAK, and 
Src signaling in cancer and cell matrix adhesions, we used the pharmacological 
inhibitors of Src family kinases PP2, and saracatinib, FAK inhibitor Pf-573358 
(FAKi), and soluble RGD and RGDS peptides to inhibit integrin on cells grown in 
2D and 3D CDM. 
 After 24 hour exposure to A549 lung adenocarcinoma cells, we found that 
treatment with the Src inhibitors PP2 and saracatinib yielded similar results in 
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inhibiting Src phosphorylation at Tyr 416, with saracatinib being slightly more 
potent and efficacious at inhibiting paxillin phosphorylation and AKT 
phosphorylation (Fig. 4A). This was coincident with an increase in FAK 
autophosphorylation upon Src inhibition. Treatment with the FAK inhibitor 
blocked the autophosphorylation of FAK and decreased Src phosphorylation. 
The RGD and RGD peptides did not appear to have much effect on integrin 
signaling and may have increased Src and paxillin activation on 3D. Next, we 
sought to determine whether these integrin signaling changes were different on 
2D fibronectin coated substrate compared to the 3D CDM. We found greater 
expression of fibronectin, a key component of cell-matrix adhesions and one of 
the proteins possessing an RGD motif, from cancer cells grown CDM compared 
to 2D and this expression was not inhibited by any pharmacological inhibitors of 
integrin or focal adhesion signaling (Fig. 4B). Interestingly, while FAK 
autophosphorylation was similar on 2D and 3D following treatment with the 
inhibitors, the soluble RGD peptides seemed to promote a phenotype on 2D 
which resembled 3D, with phosphorylation of Ser 425 of talin, a site purported to 
stabilize the talin head region and implicated migration (Huang et al., 2009), and 
activate Tyr 925 of FAK and downstream targets p-AKT, and p-paxillin. It may be 
that while the soluble RGD peptides prevent engagement with extracellular 
ligands, they also activate RGD integrin dependent signaling pathways (G. G. 
Pinkse, Jiawan-Lalai, Bruijn, & de Heer, 2005; G. G. M. Pinkse et al., 2006). 
Total FAK protein didn’t appear to be affected by treatment with any drugs on 2D 
or 3D. These findings suggest that RGD binding integrins may be mediating 
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some of the phenotypes of cancer cells observed on CDM, and that Tyr 925 
phosphorylation on FAK mediated by Src may be an important effector. 
 To determine whether this phenotype was observed in other NSCLC cells, 
we exposed the lung adenocarcinoma H2009 and A549 to varying 
concentrations of saracatinib. After 24 hours exposure, we observed drastic 
changes in cell attachment and morphology to H2009 cells grown on 3D CDM, 
with cells detaching from the matrix and contracting into distinct cell clusters at 
concentrations as low as 100 nM, while cells grown on 2D appeared less 
affected (Fig. 5A). In both cell lines, we observed similar results in which 
saracatinib appeared to be more potent in inhibiting Src activation on 3D than on 
2D (Fig. 5B). In contrast, other pathways downstream of focal adhesion signaling 
such as p44/42 MAPK (ERK1/2) signaling pathway and AKT appeared less 
effected on 3D CDM compared to 2D. These findings suggest that the effect of 
saracatinib on focal adhesion signaling on lung cancer cells grown on 3D CDM 
may be more specific to Src inhibition than to other pathways, or that other 
extracellular signals not present in 2D culture compensate for these pathways. 
Given these results, we asked whether these inhibitors would be capable of 
inhibiting lung cancer cell migration on a CDM. As we expected, it appeared that 
collective cell migration on 3D CDM required Src activation and inhibiting FAK 













Figure 3. Cell derived matrix alters collective cell migration morphology and 
directionality.  
Human adenocarcinoma cells H2030 were grown in spheroids for 4 days and transferred to 
either collagen coated plastic plates (2D) or fetal lung fibroblast IMR90 cell derived extracellular 
matrix (3D). A. Images of live cell time lapse microscopy depicting cancer cell migration from 
spheroids at 15 minutes, 6 hours, 12 hours, and 18 hours. Scale bars are 1000 µm. B. Lines 
denote migration tracks of leading cells from the spheroids on 2D or 3D substrate after 18 
hours. C. Image of the leading edge of migrating cells displays cell membrane protrusions of 
leading edge cells on a 2D substrate compared to a 3D substrate. Arrows denote characteristic 







Figure 4. Pharmacological inhibition of integrin signaling attenuates downstream focal 
adhesion pathways of lung cancer cells on CDM.  
A. A549 lung adenocarcinoma cells were grown on IMR90 cell derived matrix and treated with 
soluble RGD and RGDS peptides (100 µM), focal adhesion kinase inhibitor PF-573228 (1 µM), 
and Src kinase inhibitors Saracatinib (10 µM) and PP2 (20 µM) for 24 hours. Western blot 
analysis of extracts were probed for total focal adhesion kinase (FAK), its autophosphorylation 
site (p-FAKY397), Src and its activated state (p-srcY416), phosphorylated paxillin (Y118) and 
activated AKT (S473). Actin was used as a loading control. B. Western blot analysis of extracts 
from A549 grown on either fibronectin coated plastic (2D) or cell derived matrix (3D) and 
incubated with the indicated inhibitors for 24 hours. These extracts were probed for fibronectin, 






Figure 5. Saracatinib more potently inhibits Src phosphorylation on 3D CDM. 
H2009 and A549 lung adenocarcinoma cells were grown on either 2D or 3D cell derived matrix 
and treated with varying doses of saracatinib for 24 hours. A. Representative images of H2009 
cell morphology 24 hours after treatment with saracatinib. All scale bars are 100 µm.  B. 
Western blot analysis of extracts probed for Src, phospho-Src, phospho-AKT, FAK, phospho-







Figure 6. Inhibitors of focal adhesion signaling inhibit cancer cell migration on 3D matrix. 
A549 lung adenocarcinoma cells were plated on one side of a 3D CDM, and treated with either 
PF573228 (1 µM), Saracatinib (10 µM), or DMSO (V). Images were captured at the collective 
cell front (0 h) and 48 hours later at the same location. B. Quantification of the average migration 
distance (µm) of the cell front from the starting position. Data presented as mean ±S.E.M. from 
three independent experiments. All inhibitors were determined significantly different by ANOVA 
with Dunnett’s test for multiple comparison to vehicle, p < 0.001. 
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Environmental hypoxia promotes cell proliferation, migration, and invasion 
in a cell type specific manner 
Tumor hypoxia is a critical parameter in cancer progression as hypoxia 
inducible factor 1-alpha (hif-1α) mediates several parameters involved in 
metastasis (Majmundar, Wong, & Simon, 2010; Masoud & Li, 2015). In an 
attempt to better replicate the tumor microenvironment, we sought to use hypoxia 
as a tool to test cancer cells in an environment that more closely resembles their 
origin. Additionally, we intended to use this system as a tool to test hypoxic 
regulation of cancer cell processes associated with metastasis, invasion and 
EMT. In order to determine whether chemical or environmental hypoxia would be 
more appropriate, we compared an incubator that infused gaseous nitrogen and 
equipped with an oxygen sensor to treatment with a chemical inducer of hypoxia, 
cobalt chloride (CoCl2). A549 cells grown under both hypoxia conditions, as well 
as 2D and 3D stabilized hif-1α (Fig. 7A). However, we observed marked 
activation of a number of signaling cascades under chemical treatment that were 
not present under environmentally induced hypoxia (2% O2), with induction of the 
autophagy related protein LC3B-I, and activation of ERK, p38, and EGFR. Fewer 
differences were observed between 2D and 3D culture, save for modest 
reductions in hif-1α stabilization and AKT activation on CDM. Cancer cells grown 
on CDM also had a slight activation of EGFR. While we were not directly able to 
compare the oxygen concentration of media in either of the systems, we 
determined that environmentally induced hypoxia would allow us to better 
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observe subtle differences in signaling that may occur on the 3D CDM as well as 
allow for long term cell culture. 
Indeed, we found that A549 grown in physiologically relevant levels of 
hypoxia (5% O2) had a slight proliferative benefit after long term culture (Fig. 7B) 
and were nearly able to restore their doubling time to their traditional normoxic 
2D variable (Fig. 7C). To test whether hypoxia could induce invasion, we used a 
traditional scratch wound assay and overlaid this wound with the ECM compound 
Matrigel. Hypoxia appeared to only slightly increase invasion into the wound, but 
biochemical analysis revealed that hypoxia increased expression of the EMT 
marker vimentin, and the combination of hypoxia and a Matrigel surface induced 
activation of Src (Fig. 7D, E). This is expected since Src plays a pivotal role in the 
phosphorylation of invadopodia components cortactin, and N-WASP, and 
ultimately the recruitment of actin and MT1-MMP to invadopodia tips to promote 
invasion into ECM substrates (Bailey, Airik, Krook, Pedersen, & Lawlor, 2016; 
Mader et al., 2011). Next we sought to ask the question of whether this hypoxic 
environment could promote migration on the CDM. 
To answer this question, we created spheroids of the saracatinib sensitive 
cell line H2009 and transferred them to either a collagen coated 2D surface or a 
WI38 lung fibroblast CDM. As with the H2030 spheroids, we observed a 
remarkably different migration pattern on 2D compared to 3D CDM, with cells on 
the 2D surface migrating in a mostly radial fashion and cells on the 3D CDM 
migrating from the spheroid in long, connected single cell lines (Fig. 8). However, 
on both surfaces the cells appeared to migrate farther under hypoxic conditions 
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compared to atmospheric oxygen culture. Interestingly, we observed different 
results with the A549 and H2030 spheroids. A549 spheroids were similarly 
responsive to hypoxia and spread significantly farther from the spheroid (Fig. 
9A). This increase in cell spreading was coincident with a decrease in spheroid 
volume in hypoxia, whereas the central spheroid remained mostly intact in 
normoxia. H2030 spheroids spread equally in both atmospheric conditions (Fig. 
9B). As mentioned earlier, the H2030 cell line was derived from a metastatic 
lesion and possesses mesenchymal characteristics. It may be that the increased 
migration observed in the other cell lines is a result of EMT. Alternatively, many 
cancer cells lines have aberrant expression of hif-1α and other hypoxia response 
proteins, and while this level of hypoxia (5% O2) can induce a response in some 
cell lines, others may require a more stressful stimulus. As before, spheroid 
collective cell migration was blunted with saracatinib treatment in normoxia and 
in hypoxia. Taken together, these data suggest that environmental regulation of 
hypoxia between 2-5% O2 can promote EMT, migration, and invasion 
characteristics in lung adenocarcinoma cell lines in a cell line specific manner. 
Further, this invasive phenotype is associated with increased Src activation and 
migration on CDM matrix is effectively inhibited by blocking Src activation. Given 
that focal adhesion signaling and Src activity were necessary for cell migration of 
lung cancer cells on CDM, and that Src activity is upregulated during Matrigel 
invasion, we asked whether interactions between CDM and cancer cells could 











Figure 7. Environmental and chemical induced hypoxia differentially affect cancer cell 
signaling, proliferation, migration, and invasion.  
A. A549 lung adenocarcinoma cells grown on either 2D or 3D CDM in atmospheric O2, 2% O2, 
or treated with 1 mM CoCl2 for 24 hours. Extracts were probed for Hypoxia-inducible factor 1-
alpha (HIF1A), LC3, p44/42 MAPK and phospho-p44/42 MAPK, AKT and phospho-AKT, p38 
and phospho-p38, EGFR and phospho-EGFR (EGFRY1068). Tubulin was used as a loading 
control. B. Relative cell counts of A549 grown for 20 days in either atmospheric O2 (normoxia) 
or 5% O2 (hypoxia). Data presented as mean ±S.E.M. from three independent experiments. 
Statistical significance was determined by combining growth data for all timepoints of hypoxia 
vs normoxia using unpaired student’s t test, p < 0.025, however individual timepoints showed 
no significant differences. C. Doubling time of A549 cells following short term growth in different 
environments (Statistical analysis performed by ANOVA with Dunnett’s test for multiple 
comparison to 2DN, *p < 0.05, and ****p < 0.0001; data presented as mean ±S.E.M. from three 
independent experiments. D. A549 cells plated at confluence and a scratch wound was created 
and overlaid with Matrigel (invasion) prior to placement in normoxia or hypoxia. Quantification 
of relative wound closure at 32 h, **p < 0.01; Data presented as mean ±S.E.M. E. Western blot 
analysis of extracts from D, probed for vimentin, total Src, and activated Src (Y416). Actin was 






Figure 8. Physiological hypoxia promotes collective cell migration on 2D and 3D CDM.  
H2009 lung adenocarcinoma cells were grown as spheroids for four days and transferred to 
either a collagen coated dish or a WI38 CDM in atmospheric oxygen (N) or in a O2 controlled 
hypoxic environment similar to physiological hypoxia (H). Images were captured an hour after 
initial plating and at 48 hours. Images are representative of multiple spheroids. Note the distinct 






Figure 9. Hypoxia induced cell migration is cell line specific and inhibited by saracatinib.  
A549 and H2030 lung adenocarcinoma cells were grown as spheroids for six days and 
transferred to either a collagen coated dish or a WI38 CDM in atmospheric oxygen (N) or in a 
O2 controlled hypoxic environment similar to physiological hypoxia (H) and treated with DMSO 
or 5 µM saracatinib. A. Images were captured an hour after initial plating and at 120 hours 
(A549) or 72 hours (2030). B. Quantification of total migrated area relative to area of spheroid. 
Statistical analysis performed by ANOVA with Dunnett’s test for multiple comparison to 
normoxia at each time point, *p < 0.05, and ****p < 0.0001; data presented as mean ±S.E.M. 




Lung cancer cells on 3D CDM promote a mesenchymal mode of migration 
that potentiates invasion in-vitro 
In order to test whether the CDM could affect invasion of lung cancer cells, 
we opted to combine our two previous assays. First, we created a CDM using the 
WI38 fibroblast cell line, however we did not supplement the media with ascorbic 
acid allowing for a less collagen rich matrix that was suitable for scratching 
without destroying the entire matrix architecture on the plate. Next, we seeded 
cancer cells at confluence in order to cover the plate and created a scratch 
wound. After the scratch wound was created, we filled the wells with Matrigel 
containing either vehicle or drugs involved in inhibition of focal adhesion signaling 
(Fig. 10A). While previously we had observed a decreased migration of cells from 
the matrix into the wound area without Matrigel, remarkably we observed rapid 
wound closure of cells on the 3D CDM into the Matrigel coated wound (Fig. 10B). 
Significantly increased wound closure occurred at 6, 24, and 48 hours on 3D 
CDM compared to fibronectin coated 2D surface, with the greatest rates of 
wound closure occurring in the first 24 hours (Fig. 10C). Interestingly, when the 
cells were overlaid with Matrigel containing the FAK inhibitor PF-573228, we 
observed a blunted wound closure response on 3D CDM but not on the 2D 
substrate, such that the wound closure at 24 and 48 hours was not significantly 
different between the two substrates. This offers evidence that focal adhesion 
signaling at least in part is driving this invasive phenotype that is promoted by 3D 
CDM. Finally, we observed that inhibition of Src activity with saracatinib was 
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completely able to block wound closure in both 2D and 3D CDM, highlighting the 
importance of Src activation in supporting cell invasion. 
At this point, we had made several observations that would help us 
characterize the type of migration that is occurring when lung cancer cells were 
attached to a 3D CDM. Currently, two major forms of migration are thought to 
occur in a 3D context, amoeboid and mesenchymal. Cancer cells undergo 
plasticity that allows transition between these two states in order to facilitate 
migration through soft or dense fibrous matrices. Likely, within a population, both 
types of migration are occurring but exist on a spectrum of characteristics 
determined by the balance of signaling which occurs in response to the surface 
with which cells are interacting. Notably in our experimental context, the 
morphology of the cells appears to be much more elongated and spindle shaped 
similarly to fibroblasts as the cells align along the matrix. We also observed long, 
cellular protrusions from the cells interacting with the ECM. Additionally, the 
migration and invasion promoted by CDM interaction seem to be blunted by 
blocking integrin based focal adhesion signaling. Considering these findings, we 
hypothesized that the CDM was promoting a mesenchymal mode of migration 
that was also facilitating the invasion into Matrigel. 
At the molecular level, the dynamics of the actin cytoskeleton and the 
contraction of myosin are defined characteristics in determining the modality of 
migration in 3D (Paňková, Rösel, Novotný, & Brábek, 2010). During amoeboid 
migration, actomyosin contractility driven by phosphorylated myosin light chain 
(pMLC) downstream of RhoA and ROCK is high. Conversely, during 
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mesenchymal migration, Rac1 predominates, inhibiting RhoA signaling and 
promoting actin assembly and protrusion. To test whether we could recapitulate 
the invasive phenotype we observed on 3D CDM using a 2D substrate, we 
overlaid a scratch wound with Matrigel that contained the ROCK inhibitor GSK-
269962. We found that treating cells on a 2D substrate with the ROCK inhibitor 
promoted similar characteristics as cells on a 3D CDM, with long cellular 
projections and increased wound closure that was significantly different from 
vehicle treated cells in 2D at 24 and 48 hours, but not significantly different from 
vehicle treated cells on 3D CDM (Fig. 11A). Western blot analysis of lysates 
produced from this experiment showed an increase in Src activation with low 
levels of ROCK inhibition on 2D, but no change in FAK autoactivation (Fig. 11B). 
Interestingly, further analysis of the microarray of lung cancer cells on 2D and 3D 
CDM performed previously in our lab showed that expression of myosin light 
chain kinase (MLCK), another kinase associated with pMLC, is downregulated on 
CDM. Together, this evidence suggests that CDM interactions may promote a 
mesenchymal migration phenotype that promotes invasion of Matrigel through 
activation of Src. 
Since we have determined the importance of focal adhesion signaling and 
Src activation on increased invasion of cancer cells on CDM, we attempted to 
use western blot analysis to determine some of the molecular changes that were 
occurring with pharmacological inhibition of different components of this pathway 
(Fig. 12A). We found that integrin αV, one of the integrin receptor heterodimer 
components important in binding to fibronectin and other RGD peptides, was 
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upregulated on CDM compared to 2D, that this expression was not decreased by 
FAK, Src, or ROCK inhibition, but was decreased by treatment with the cyclic 
RGD peptide cilengitide. This suggests that the RGD peptides we’ve used are 
likely inhibiting their intended targets, however again we see that treatment of 
cancer cells on a 2D substrate with cilengitide promotes a molecular response 
that resembles cells grown on a CDM, with similar Src expression and activation, 
paxillin phosphorylation, annexin II phosphorylation, and RhoA expression. 
Similarly, EMT markers also appeared to be similar upon cilengitide treatment of 
cancer cells on a 2D substrate and vehicle treatment on a 3D substrate with 
decreased e-cadherin expression and increased expression of Zeb1 and 
vimentin (Fig. 12B). A possible explanation for this result may be due to the 
internalization of integrin αV following treatment corresponding with a switch to 
another integrin heterodimer pair at the cell surface. This result was 
demonstrated to occur by Jim Norman’s lab, where ovarian carcinoma cells were 
treated with cilengitide or osteopontin and as a result recycled integrin α5β1 to 
the cell surface to promote cell adhesion to fibronectin and mediate EGFR driven 
migration into a 3D matrix (Caswell et al., 2008). This suggests the possibility 
that a similar mechanism is occurring with lung cancer cells adhering to a lung 
fibroblast CDM as in the original hypothesis, however further characterization of 
surface integrin expression would be required for verification. On the other hand, 
treatment with the focal adhesion inhibitors did not appear to affect integrin 
expression or stat3 activation, however they all seemed to promote increased 
Src expression and RhoA, perhaps in a compensatory response. Saracatinib 
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treatment was the only agent that appeared to greatly diminish activation of 
downstream Src targets paxillin and annexin II. We observed a similar inhibition 
of the EMT phenotype when cells were treated with focal adhesion inhibitors, 
with stabilization of e-cadherin of cells on 3D CDM, an increase of zeb1 
expression, and a decrease of vimentin. Zeb1, a negative regulator of e-cadherin 
expression, is promoted by stat3 activation (Xiong et al., 2012), and this pathway 
appears to play a role in CDM mediated promotion of EMT (Fig. 12B). 
Interestingly, blocking focal adhesion signaling restored e-cadherin expression 
and diminished vimentin expression of cancer cells grown on CDM, even though 
stat3 was activated and zeb1 expression increased, highlighting the importance 
of cell-matrix interactions in regulating the EMT phenotype. We investigated 
other known regulators of EMT, snail and slug, however we were unable to 
resolve a clear picture of their expression and this may be improved by using a 
nuclear extract in the future.  
The EMT marker plasminogen activator inhibitor-1 (PAI-1) had 
pronounced expression in cancer cells on CDM upon treatment with saracatinib. 
PAI-1 regulates pericellular proteolysis by directly inhibiting the activation of 
plasminogen to plasmin by binding and inactivating plasminogen activators, 
urokinase and tissue type plasminogen activator. Plasmin has been 
demonstrated to have a broad spectrum of activity in activating zymogens of a 
multitude of MMPs in vitro including MMP-1, MMP-2, MMP-3, MMP-9, MMP-13, 
and MMP-14 (Deryugina & Quigley, 2012). Given the drastically decreased 
invasion upon saracatinib treatment and the importance of pericellular proteolysis 
62 
 
for invasion, we decided to investigate the role pai-1 played in lung cancer cells 
on the CDM. Of the three lung adenocarcinoma cell lines test, H2009, H2030, 
and A549, only the A549 cell line had high levels of PAI-1 expression, although 
the other cell lines had variable expression of related serine protease family 
members PAI-2 and PN-1 (Fig. 13A). To understand the role of PAI-1 in cell 
migration and invasion, we generated lentivirus containing CRISPR/cas9 
constructs containing two different guides targeting PAI-1, a non-targeting guide, 
and a pLX304 expression vector with the human SERPINE1 cDNA and stably 
infected the three different cell lines. Upon expression of PAI-1 in H2009 cells, 
we observed a slight but significant decrease in cell migration compared to NT, 
while knock out of PAI-1 did not affect the cells (Fig. 13B).  
In order to establish complete knock out of PAI-1 in A549 cells, we 
isolated and characterized several clones from each of the guides (Fig. 13C) and 
compared PAI-1 expression to both NT and PAI-1 overexpression clones. Loss 
of PAI-1 in A549 cells significantly increased migration in clones manipulated 
with either guide compared to NT, while stable expression of PAI-1 did not affect 
migration in a scratch wound assay (Fig. 13D). We observed a similar result 
when we assessed migration on the 3D cell derived matrix, however A549 stably 
expressing PAI-1 appeared to be less migratory on ECM compared to the NT 
clone (Fig. 13E). To test the ability of PAI-1 to modulate cell invasion and 
proteolysis, we employed the 3D CDM Matrigel invasion assay in combination 
with the pan-MMP inhibitor GM-6001, which targets MMP-1, MMP-2, MMP-3, 
MMP-8, and MMP-9. Intriguingly, PAI-1 KO clones rapidly invaded into the 
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wound irrespective of the MMP inhibitor, however 3D invasion was slowed with 
stable expression of PAI-1 and nearly completely halted with the combination of 
PAI-1 expression and treatment with the MMP inhibitor (Fig. 13F). It may be that 
PAI-1 expression of the cells and GM-6001 treatment cover a broad range of 
potential MMPs involved in Matrigel degradation. Alternatively, unrestricted 
plasminogen activation may have effects on targets other than MMP as plasmin 
directly degrades several ECM proteins. Together, these data demonstrate the 
importance of pericellular proteolysis in invasion into Matrigel, and that 
interrupting these processes can modulate the migratory and invasive potential of 













Figure 10. CDM promotes cancer cell invasion of Matrigel which is inhibited by blocking 
focal adhesion signaling.  
A. Schematic representation of the scratch wound invasion assay. Cancer cells are grown on 
2D or 3D CDM at confluence and a scratch wound is created. The well area is then either 
overlaid with complete media containing Matrigel and treated with focal adhesion inhibitors 
PF573228 (Faki 1µM), saracatinib (10µM), or vehicle (DMSO). Images of the scratch wound 
area are captured at 0, 6, 24, and 48 h. B. Representative images of Matrigel wound invasion 
by A549 lung adenocarcinoma cells at 0 h and 24 h on 2D surface or CDM. C. Quantification 
of wound closure over a 48 h period. Each symbol represents the mean of an individual 
experiment with two technical replicates. Dotted lines indicate means of multiple experiments 
treated with DMSO, while solid lines indicate means of multiple experiments treated with drug. 
Statistical analysis performed by ANOVA with Tukey’s test for multiple comparison at each time 
point (DMSO: 2D v 3D; FAKi: 2D vehicle v 3D drug; Saracatinib: vehicle v drug) , *p < 0.05, **p 






Figure 11. Rho kinase signaling inhibition promotes cancer cell Src expression and Matrigel 
invasion on a 2D substrate. 
A549 lung adenocarcinoma cells were plated at confluence on either 2D (closed symbol) or 3D CDM 
(open symbol), scratched, and the wound was overlaid with Matrigel containing Rho kinase inhibitor 
GSK269962 (1 µM or 5 µM). A. Quantification of Matrigel wound invasion at 6, 24, and 48 h. Dashed line 
indicates vehicle treatment from previous figure. Each symbol represents the mean of an individual 
experiment with two technical replicates. Statistical analysis performed by ANOVA with Tukey’s test for 
multiple comparison at each time point between drug and vehicle on 2DN, **p < 0.01, and ***p < 0.001; 
data presented as mean ±S.E.M. from at least two independent experiments. B. Western blot analysis of 
extracts from the 48 hour timepoint of the invasion assay were probed for Src, phospho-Src, phospho-


















Figure 12. Analysis of focal adhesion pathway signaling during 3D CDM induced 
invasion into Matrigel reveals roles for Src and EMT.  
Lysates prepared from A549 during the Matrigel invasion assay treated with either DMSO, PF-
573228 1µM, Saracatinib 10 µM, GSK269962 5 µM, or Cilengitide 1 µM for 48 hours on 
fibronectin coated 2D or WI38 CDM 3D were probed for members of the focal adhesion 
signaling pathway and proteins associated with Src activation. A. Western blot analysis of 
integrins β3 and αV, one of the heterodimer pairs known to recognize the RGD motif of 
fibronectin, activated stat3, Src, activated Src, targets of Src: phosphorylated paxillin, annexin 
II and phosphorylated Tyr 24 of annexin II, and the Rho family GTPase RhoA. B. Western blot 
analysis of EMT markers E-cadherin, Zeb1, vimentin, slug, snail, and plasminogen activator 










Figure 13. PAI-1 mediates cell migration and invasion of lung adenocarcinoma cell lines 
on CDM. 
A. Western blot analysis of lysates from H2009, H2030, and A549 lung adenocarcinoma cell 
lines grown in normoxia or physiological hypoxia (5% O2) for 24 hours were probed for PAI-1, 
and related serine protease family members plasminogen activator inhibitor-2 (PAI-2) and 
protease nexin-1 (PN-1). Tubulin was used as a loading control. B. H2009 cells were infected 
with a lentiviral Crispr/cas9 targeting pai-1 with two different guides (g2 and g3), a non-targeting 
guide (NT), and a human pai-1 expression vector. Relative wound closure of a scratch wound 
(migration) in modified 2009 cells 18 hours after wounding. Each symbol represents an 
independent experiment mean of two technical replicates. Statistical analysis performed by 
ANOVA with Dunnett’s test for multiple comparison to NT, **p < 0.01; data presented as mean 
±S.E.M. from three independent experiments. C. Western blot analysis of single clone cell lines 
from A549 infected with lentiviral Crispr/cas9 and pai-1 expression plasmid probed for pai-1. D. 
Relative wound closure of a scratch wound (migration) after 24 hours from selected clones with 
pai-1 knock out or overexpression. E. Pai-1 knock out, NT, and overexpression A549 spheroids 
were transferred to a IMR90 CDM and images were captured at 0 hours and 96 hours after 
attachment. F. Pai-1 knock-out or overexpression A549 cells were plated on WI38 CDM at 
confluence, scratched, and overlaid with Matrigel with either MMP inhibitor GM-6001 (25 µM) 
or vehicle. Quantification of relative wound closure (invasion) at 6, 24, and 48 hours. Each 




In the present study, we investigated the influence of integrin signaling in 
lung cancer cells attached to a fetal lung fibroblast derived extracellular matrix on 
cellular processes relevant to cancer metastasis including cell migration, 
invasion, and the EMT. As our lab has previously demonstrated (Scherzer et al., 
2015), lung cancer cells on 3D CDM alter their migratory behavior on a CDM 
compared to a fibronectin or collagen coated 2D surface. In the context of 
collective cell migration, we found that cells maintain directional migration on a 
CDM similarly to single cell migration. Surprisingly, we see that during collective 
cell migration, cells on a 2D surface appear to migrate at an isotropic average 
velocity that is faster than the anisotropic velocity exhibited by cells on CDM (Fig. 
3). Live cell imaging revealed that as cells move collectively on 3D CDM, leader 
cells extend pseudopodal projections and rapidly assemble and disassemble 
cell-matrix adhesions to the ECM substrate. While precise identification of cell-
matrix adhesions was beyond the scope of this study, we found that signaling 
cascades downstream of integrin signaling, namely FAK and Src signaling were 
required for cell migration on 3D CDM as pharmacological inhibitors of FAK and 
Src slowed migration (Fig. 6). 
Inhibition of Src activation appeared to be more potent on cells in the 3D 
CDM compared to 2D, with diminished perturbations of AKT and ERK signaling 
pathways (Fig. 5). Considering the frequent association of cell-matrix adhesions 
with fibronectin, we anticipated that blocking the integrin association with the 
fibronectin component of the ECM by treatment with soluble RGD peptide may 
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also block the phenotypic effects observed with cell attachment to the ECM, 
however upon treatment we found expression and activation of integrin signaling 
pathways on 2D resembled untreated 3D CDM controls (Fig. 5). As we observed 
this phenomenon with three RGD peptide based inhibitors (RGD, RGDS, and 
cilengitide), this warrants further investigation of integrin “outside-in” signaling 
using other tools of exogenous integrin activation, such as manganese, and 
inactivation through activation blocking antibodies such as the anti-integrin β1 
antibody P5D2 or the α5β1 antibody volociximab (Bhaskar et al., 2007; Ye, Kim, 
& Ginsberg, 2012). As the 3D CDM matrix model is particularly suited to cell 
microscopy, further evaluation of cell-matrix adhesion components and their 
localization upon attachment to ECM through fluorescent confocal microscopy 
would also help in delineating specific integrin interactions. 
A critical component of metastasis is cell invasion of dysplastic cells 
through the basement membrane layer of epithelial tissues and intravasation 
through endothelial lining. To model this behavior within the tumor 
microenvironment, we added the element of environmental hypoxia to our cell 
culture model in order to create a microenvironment mimetic in-vitro system. A 
benefit of our system is that we are able to control the atmospheric O2 level to 
between 2% and 20% that is similar to the O2 saturation of most tissues within 
the body. While this is not as hypoxic as some reported levels of hypoxia in the 
tumor microenvironment (Petrova et al., 2018; Salem et al., 2018), it is sufficient 
to induce stabilization of HIF-1α (Fig 7). Additionally, we demonstrate that this 
level of hypoxia supports and enhances cell proliferation for long term cell culture 
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and potentiates invasion in A549 cells, which is correlated with induction of EMT 
and activation of Src. However, hypoxia did not affect all cancer cell lines equally 
as migration was increased with A549, but not with H2009 or H2030 (Fig. 9). One 
possibility is the origin of the cell lines, as A549 was originally cultured from a 
primary lung explant and the H2009 and H2030 were originally derived from 
metastatic tissue. While they are all KRAS mutant lung adenocarcinoma cell 
lines, differences may exist in their capacity to undergo and maintain an EMT 
phenotype (Schliekelman et al., 2015).  
Outside of the context of hypoxia, lung cancer cell interaction with 3D 
CDM promoted Matrigel invasion compared to 2D culture. Treatment with a FAK 
kinase inhibitor slowed this 3D promoted invasion to 2D levels, whereas Src 
inhibition decreased invasion in both conditions, albeit to a greater extent on 3D 
CDM. Analysis of microarray studies performed by Scherzer et al. identified that 
MLCK was downregulated on two different CDMs in A549 and H358 cell lines 
compared to 2D fibronectin controls. One of the targets of MLCK is the activation 
of MLC and blocking this activation through pharmacological inhibition of the 
Rho/Rock pathway resulted in increasing the invasive capacity of lung cancer 
cells on 2D (Fig. 10). This also correlated with increased Src activation. Inhibitors 
of focal adhesion signaling all stabilized e-cadherin and decreased expression of 
vimentin, suggesting that this signaling pathway is also involved in the regulation 
of EMT on 3D CDM (Fig. 12). However, PAI-1 expression appeared to be 
markedly increased by saracatinib treatment on 3D CDM, leading us to ask about 
the role of ECM remodeling and pericellular proteolysis on cancer invasion. 
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Of the three cell lines tested, only A549 had appreciable PAI-1 expression 
(Fig. 13). Restoring PAI-1 in the deficient cell line H2009 decreased migration, 
whereas KO of PAI-1 in A549 increased migration on 2D and 3D. KO of PAI-1 
also increased 3D invasion, but this was not inhibited by MMP inhibitor GM6001, 
suggesting that loss of PAI-1 in lung cancer cells may increase invasion in a 
mechanism that does not involve extracellular regulation of MMP but may involve 
an intracellular target. 
Collectively, we see that the interaction of cancer cells with the 
extracellular matrix alters migration and promotes invasion through focal 
adhesion signaling.  Cancer cell interaction with 3D CDM promotes an elongated 
cell phenotype, directional migration, EMT, invasion, and is affected by protease 
regulation. Additionally, cells on 2D can transition to a 3D-like phenotype with 
inhibition of Rho/ROCK and presumably through altering actomyosin related 
cortical contractility. These findings suggest that interaction with a lung fibroblast 
CDM promotes a mesenchymal mode of migration, that this modality of migration 
is inhibited by blocking focal adhesion signaling, and also promotes local 
invasion into the basement membrane. While FAK inhibition slows invasion on 
3D substrates, Src inhibition blocks invasion in 2D and 3D environments, while 
not affecting AKT or ERK activation in the cancer cell lines tested. Src inhibition 
on 3D CDM was associated with increased expression of PAI-1, and modulation 
of PAI-1 expression in cancer cells altered the migratory and invasive phenotype. 
Within the tumor microenvironment, cell extrinsic elements such as the 
interaction with extracellular matrix, and cell intrinsic elements such as the 
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expression and regulation of proteases and PAI-1 engage in a dynamic interplay 
to promote cancer cell invasion. Further understanding of essential Src 
substrates or interactors in 3D environments, particularly related to invadopodia, 
proteases, and their regulation may lead to improved therapeutic targets in lung 
cancer metastasis. 
 
(Portions of this chapter are published in Scientific Reports. (Saforo et al., 2019)) 
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CHAPTER IV: TUMOR MICROENVIRONMENT MIMETIC CULTURE 
AIDS ISOLATION, EXPANSION, AND POTENCY OF TUMOR 
STROMAL PROGENITORS FROM PRIMARY LUNG CANCER 
RESECTIONS 
INTRODUCTION 
The tumor microenvironment consists of a diverse milieu of transformed 
and non-transformed cells that ultimately coordinate to build and maintain a 
physical environment that supports tumor growth and potentiates escape and 
establishment at secondary systemic sites (Quail & Joyce, 2013). These 
constituents act in concert and dynamically regulate a pathological 
microenvironment that modulates physical characteristics within the tumor such 
as tissue stiffness, oxygen tension, and metabolite availability (Erler & Weaver, 
2009; Nelson & Bissell, 2006; Vaupel, 2004). As tumors grow, these elements 
promote the hallmarks of cancer such as sustaining proliferative signaling, 
evading immune cell death, inducing angiogenesis, and activating invasion and 
metastasis (Hanahan & Weinberg, 2011). Recent evidence implicates an 
activated tumor stroma as enablers of these processes (Bremnes et al., 2011; 
Pietras & Ostman, 2010). 
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The constituents of the non-tumor elements within the stroma are multiple 
and varied, however the cancer associated fibroblasts (CAF) are thought to be a 
major contributor to the TME stroma (Bremnes et al., 2011). CAF currently lack 
specific markers but display characteristics similar to activated fibroblasts such 
as expression of alpha-smooth muscle actin (αSMA) and vimentin (Amatangelo, 
Bassi, Klein-Szanto, & Cukierman, 2005). They act in paracrine fashion by 
producing potent proliferative cytokines that elicit mitogenic signaling within 
tumor cells. Furthermore, these CAF also can directly stimulate angiogenesis via 
secretion of vascular endothelial growth factor (VEGFA) and activate invasion via 
production of transforming growth factor beta (TGF-β) (Navab et al., 2011; Y. 
Zhang et al., 2011). CAF produce a modified extracellular matrix (ECM) which 
acts as a bioactive mechanical scaffold that can influence tumor cell survival and 
metastasis, as well as matrix metalloproteinases (MMP) that allow the dynamic 
regulation of the ECM architecture through degradation of local matrix proteins 
and activation of latent growth factors within the matrix (Cox & Erler, 2011). 
Despite these critical effects on tumor homeostasis and progression, the 
origin of the CAF remains elusive and may arise from a heterogeneous number 
of cell types. Evidence has shown that CAF possess many characteristics of 
mesenchymal stem cells, implicating these cells as a possible origin of the CAF 
(Kalluri, 2016). Unfortunately, pre-clinical studies of the origin of the tumor stroma 
are hampered by several challenges. Primary samples from patient tumor 
resections are limited and this material is valuable for the diagnosis of the 
patient. Primary cancer cell lines may be more sought after from this material, 
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and successful transformation of cancer cell lines currently requires repeated 
xenografts in mice during which time the tumor microenvironment is replaced by 
mouse stroma (Gaggioli et al., 2007). In-vitro methods to obtain cell lines from 
primary tissue resection are hindered by time to cell isolation, and these cells can 
acquire changes in-vitro during the time it takes to passage them in traditional 
cell culture conditions. During this time progenitor cell types may differentiate, 
become quiescent, or undergo apoptosis (McKee & Chaudhry, 2017). 
Various strategies have been developed to better isolate progenitor cell 
types. The ECM, which is well known to modulate cell behavior through 
mechanism of its mechanical stiffness, protein composition, crosslinking, and 
bioactive components, has also been shown to improve culture of bone marrow 
mesenchymal stem cells (MSC) (X. D. Chen et al., 2007). Culture dishes are 
frequently coated with components of this extracellular matrix to promote the 
adhesion and differentiation of a variety of cell types. Previously, we and others 
have shown that cell-derived extracellular matrices (CDM) are replicative of the 
in-vivo environment and influence cancer cell signaling to recapitulate 
tumorigenic processes in-vitro (Castello-Cros, Khan, Simons, Valianou, & 
Cukierman, 2009; Scherzer et al., 2015; Yamada & Cukierman, 2007). We have 
shown that fetal human lung fibroblasts produce a CDM that supports lung 
adenocarcinoma cells to regulate EMT processes and provide survival signaling 




Hypoxia is a critical factor in the tumor progression of solid cancers (Le et 
al., 2006). Oxygen tension in physical tissues is around 2-8% and plays a role in 
regulating metabolic homeostasis. Intratumoral oxygen tension can be much 
lower (<0.1%) (Carreau, El Hafny-Rahbi, Matejuk, Grillon, & Kieda, 2011). In-vitro 
systems that control oxygen tension have provided proliferative benefits to a 
number of stromal cell types compared to traditional culture in atmospheric 
normoxia (20% O2) (Mizuno et al., 2009). Culturing at physiological levels of 
hypoxia has previously been reported to be critical for the cultivation and 
maintenance of human stem cells (Grayson, Zhao, Bunnell, & Ma, 2007). 
We hypothesized that these factors, physiological hypoxia and an in-vivo-
like extracellular matrix, are crucial to maintain tumor stroma, and that 
incorporating these elements in a microenvironment mimetic in-vitro model would 
improve survival and cultivation of primary cells from small quantities of patient 
tumor resections. To test this hypothesis, we collected cells from tumor 
resections of six patients with non-small cell lung carcinoma (NSCLC) and grew 
them from isolation in different in-vitro environmental conditions. Utilizing a 
combination of cell derived ECM and physiological hypoxia, we were able to 
rapidly cultivate and massively expand populations of patient tumor associated 
stromal progenitors.  
 




Microenvironment mimetic culture system characterization.  
Various approaches have been used to attempt to isolate progenitor 
populations from tumors and bone marrow including serum withdrawal and 
specific conditioned medium, using specialized culture techniques such as 
hypoxia and extracellular matrix proteins, and culturing cells using 3-dimensional 
scaffolds or suspension culture. A commonality of these approaches is that each 
attempt to simulate certain aspects of the physiological condition to limit the 
growth of non-progenitor cell types and optimize expansion of rare or quiescent 
progenitors. In order to test the hypothesis that an in-vitro culturing system 
resembling the microenvironment of the human lung would facilitate the isolation 
and expansion of sensitive primary patient tumor cell populations, we developed 
a microenvironment mimetic culturing system that includes a fibroblast derived 
extracellular matrix (ECM) and an atmosphere that maintained the oxygen 
tension at a physiological level (Fig. 14A). 
To characterize this system, we assessed each environmental component 
individually (tissue culture plastic in atmospheric oxygen (2DN), tissue culture 
plastic in physiological hypoxia (2DH), cell-derived ECM in atmospheric oxygen 
(3DN), and cell derived ECM in physiological hypoxia (3DH)), and utilized two 
fetal human lung fibroblast cell lines, IMR90 and WI38, and a human bone 
marrow mesenchymal stem cell line (hMSC). After 72 hours of growth in each 
environment, we observed a qualitative increase in WI38 cell number in single 
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conditions of 2DH or 3DN compared to 2DN, as well as an increase in cell 
number in 3DH (Fig. 14B). Similarly, we observed the greatest increase in cell 
number for all cell lines in the microenvironment mimetic system that combined 
physiological hypoxia and cell-derived extracellular matrix (Fig. 15). 
Quantification of mean cell doubling time (Fig. 14C) in the 3DH environment 
showed significant decreases in IMR90 (P < 0.0099), WI38 (P < 0.0039), and 
hMSC (P < 0.0001), compared to the other conditions. The single condition of 
physiological hypoxia significantly decreased mean doubling time only for the 
IMR90 cell line (P < 0.0387).  
To assess whether the physiological hypoxia environment induced a 
measurable oxygen response in the cells, we assessed stabilization of hypoxia-
inducible factor 1, a global regulator of oxygen homeostasis. Although western 
blot analysis revealed a stabilization of hypoxia-inducible factor 1 alpha subunit 
(HIF1A) in the physiological hypoxia environments (2DH and 3DH) after 72 
hours, there was a considerable decrease in HIF1A stabilization in the 3DH 
environment compared to the 2DH environment (Fig. 14D). Previously it was 
reported that cell-derived matrices generated from stroma of various stages of 
tumor progression can activate fibroblasts to undergo myofibroblastic and 
desmoplastic activation (Amatangelo et al., 2005). To ensure that the matrices 
from human fetal lung fibroblasts in our system were not inducing a desmoplastic 
response in the cells, we assessed the expression of alpha smooth muscle actin 
(A-SMA), a marker of activated myofibroblasts and desmoplastic stroma. We 
found that A-SMA expression decreased in fibroblasts cultured on cell derived 
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matrix and was variably affected by hypoxia, with a slight decrease in IMR90. 
Additionally, we investigated regulators of cell cycle progression, and found cell 
cycle inhibitors p21 Waf1/Cip1 (p21) and p27 Kip1 (p27) were also decreased in 
the 3DH condition relative to the single 2DH and 3DN conditions. Taken together, 
our findings suggest that despite long term culture in typical cell culture 
conditions, commonly used mesenchymal fibroblast and stem cell lines cultured 
in a microenvironment mimetic system experience a proliferative benefit while not 
invoking a desmoplastic transformation, properties essential to the establishment 






Figure 14. Physiological hypoxia and cell derived matrix enhance proliferation of stromal 
cell lines and are non-desmoplastic.  
A. Schematic of cell derived matrix preparation from IMR90 fetal lung fibroblast cell line and 
characteristics of microenvironment mimetic conditions. B. Phase contrast images of equal 
numbers WI38 fetal lung fibroblast cells grown for 72 hours in four environmental conditions 
(2D Normoxia, 2D Hypoxia, 3D Normoxia, and 3D Hypoxia). Scale bars are 100µm. C. Doubling 
time of WI38, IMR90, and bone marrow mesenchymal stem cell line hMSC following short term 
growth in different environments (Statistical analysis performed by ANOVA with Dunnett’s test 
for multiple comparison to 2DN, *p < 0.05, **p < 0.01, and ****p < 0.0001; data presented as 
mean ±S.E.M.)  D. Western blot analysis of hypoxia inducible factor 1 alpha (Hif1a), alpha 
smooth muscle actin (α-SMA), and cell cycle inhibitors (p21, p27) from WI38 and IMR90 after 








Figure 15. Physiological hypoxia and cell derived matrix enhance proliferation of stem 
and fetal stromal cell lines.  
Phase contrast images of equal numbers hMSC and IMR90 fetal lung fibroblast cells grown for 
72 hours in four environmental conditions (2D Normoxia, 2D Hypoxia, 3D Normoxia, and 3D 




Enhanced cell isolation and proliferation from patient tumor biopsy. 
A challenge to preclinical testing of patient tumors is that resected material 
is limited and precious for obtaining crucial diagnostic information. Progenitor 
populations within tumors are thought to be a rare subset of this already limited 
tissue. To test the hypothesis that a microenvironment mimetic cell culture 
system would improve the yield of sensitive progenitor cells present within 
tumors, we obtained six primary tumor resections from treatment naïve patients 
with non-small cell lung carcinoma (NSCLC), including three squamous cell 
carcinoma and three adenocarcinoma tumors (Table 3). In these patients, 
metastasis could not be measured at the time of resection (MX) and samples 
from one of the patients (1072) was later determined to have cancer present in 2 
of 11 lymph nodes (N1). Specimens from the remaining tumor resections did not 
have metastasis present in the lymph nodes. A portion of these resections were 
prepared by enzymatic digestion to create single cell suspensions, and equal 
quantities of cells were seeded onto various cell culture conditions. 
The first sample tested, 927, was seeded onto the four environmental 
conditions detailed above and monitored with microscopy. Seven days post 
isolation, we observed cell populations of elongated and spindle cell morphology 
in every environmental condition (Fig. 16A). There appeared to be an increase in 
the number of attached cells in the 2DH and 3DN environments compared to the 
traditional 2DN environment, however, remarkably, we observed massive 
outgrowths of colonies and migrated cells in the 3DH environment. Cells 
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continued to proliferate in both physiological hypoxia environments but did not 
passage in the normoxia environments despite presence of extracellular matrix. 
We found that all tumor samples tested in the 3DH environment showed a 
marked increase in attached and proliferating cells post isolation compared to 
traditional cell culture methods (Fig. 16B, D), however we did not observe any 
increase in primary cell survival from adjacent normal tissue (Fig. 16C). While the 
3DH environment greatly enhanced the proliferative capacity of each tumor 
sample, allowing the first passage after 7 days, in most cases cells grown in 
traditional methods produced a viable cell line after a moderate delay (Fig. 16D). 
Similarly, when cells that were isolated in 3DH were transferred to the other 
environments, we found that the cells were still viable though their proliferation 
slowed (Fig. 16E). In four biological replicates, we found that the mean doubling 
time significantly decreased (P < 0.009) in the 3DH environment (20.25 ± 0.7147, 
n=4) compared to transfer to a traditional cell culture environment (42.82 ± 3.643, 
n=4). These data indicate that a microenvironment mimetic system indeed 
accelerates the establishment of a heterogeneous cell line from NSCLC 
















CDSR00927 squamous cell T2aN0MX III M white 56 4300 
CDSR00955 squamous cell T1bN0MX II M white 68 T:110000; 
N:12000 
CDSR00956  adenocarcinoma T1bN0MX II F black 59 150000 
CDSR00959  adenocarcinoma T3N0MX II F white 75 130000 
CDSR00960  squamous cell T3N0MX III M white 73 57000 
CDSR01072  adenocarcinoma T2N1MX III F white 75 4444 
Table 3. Patient Sample Characteristics. 





Figure 16. Physiological hypoxia and cell derived matrix synergistically enhance 
proliferation of Patient Tumor Stromal-like cells. 
Resected tumors were enzymatically digested with collagenase/dispase and single cell 
suspensions were grown on four environmental conditions (2DN, 2DH, 3DN, 3DH). A. 
Representative phase contrast images (from 5 random fields) of patient sample 927 cell growth 
7 days post isolation in each condition. Scale bars are 100µm. B. Phase contrast images of 
patient samples 956 and 959 obtained 7 and 6 days after isolation in 2DN and 3DH. C. Phase 
contrast images of patient sample 955 tumor and adjacent normal lung cells 9 days post 
isolation. D. Total cell numbers and days post isolation of 4 patient samples grown in 2D 
Normoxia and 3D Hypoxia at the time of first and third passaging. E. (Upper) Doubling time of 
3DH derived 927 cell line upon transfer to 4 environmental conditions. (Lower) Doubling time 
of patient derived cell lines maintained in 3DH or transferred to 2DN. Statistical analysis 







Figure 17. Population doubling level of patient sample cell lines.  
A. Images of patient tumor resections prior to dissection and dissociation. Scale bars are 1 cm. 
B. Phase contrast images of dissociated tumor cell growth from sample 956 7 days post 
isolation showing a heterogenous cell population. Arrowheads indicate clumps of non-
fibroblastic colonies. Scale bars are 100mM. C. Population doubling level of cell lines derived 




Primary tumor cell mesenchymal lineage characterization and 
immunophenotyping.  
While we observed a heterogenous population of cell morphologies in the 
first week of cell isolation (Fig. 17), the spindle-shaped cells quickly outpaced the 
other cell populations. We tested protein expression of epithelial and 
mesenchymal cell lineages and found that while the 927 tumor resection was 
highly positive for e-cadherin expression, cell lines derived from the resection 
were highly vimentin positive with undetectable e-cadherin expression (Fig. 18A). 
Similarly, cell lines derived from the other tumor resections did not express 
detectable levels of E-cadherin or Pan-cytokeratin but were also highly vimentin 
positive. Given the high proliferative capability and strict cell culture conditions 
utilized in the isolation, we suspected this cell type may be a mesenchymal stem 
cell. We measured surface expression of well characterized mesenchymal stem 
cell markers CD90 (Thy1), CD73 (NT5E), and CD105 (Endoglin) (Fig. 18B). The 
tumor derived cell lines expressed CD73 in the highest quantity, with the majority 
also staining positive for CD90 as well as CD105. 
Mesenchymal stem cells are also defined by their ability to adhere to 
tissue culture plastic and form colonies from colony-forming unit-fibroblasts 
(CFU-F). Populations of CFU-F were significantly different between patient 
sample cell lines, IMR90 fetal fibroblasts, and hMSC (F (6,18) = 21.32, P < 
0.0001) by one-way ANOVA. Upon multiple comparisons, all patient sample cell 
lines possessed significantly greater CFU-F populations compared to IMR90 fetal 
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fibroblasts (P < 0.0314), however tumor sample 959 derived in 3DH was 
distinguished with significantly greater CFU-F compared to either hMSC or the 
other tumor samples (P < 0.0003). There was no significant difference in tumor 
samples 927, 955, or 1072 in colony forming ability compared to hMSC (Fig. 
18C). Interestingly, the environment that tumor sample 959 was originally 
cultivated in had a significant effect (P < 0.0003) on maintenance of colony 
progenitors, where the 3DH environment maintained a greater quantity of 
progenitors compared to traditional 2DN conditions. Taken together, these 
findings suggest that culturing cells derived from NSCLC in a lung 
microenvironment mimetic environment rapidly selects for mesenchymal stromal 
cells with stem-like characteristics. Given the delay in growth in traditional 
conditions and that at least one of the samples showed a difference in progenitor 
characteristics depending on the environment in which it was derived, we asked 


















Figure 18. 3DH Patient derived stromal cell lines are mesenchymal and possess 
mesenchymal stem cell-like characteristics. 
A. Western blot analysis of tumor resection 927 and its tumor derived cell lines, fetal lung 
fibroblast cell line IMR90, and lung adenocarcinoma cell line A549 (upper). Western blot 
analysis of additional tumor resections and their derived cell lines probing for expression of 
pan-cytokeratin (lower). B. Immunophenotyping of 3DH tumor derived cell lines with commonly 
identified antigens associated with MSC (Y-axis: CD90, X-axes: CD105 (left) and CD73 (right)). 
C. Quantification of Colony Forming Unit-Fibroblast (CFU-F) per 25 cells plated in 3DH tumor 
derived cell lines, a matched 2DN derived cell line (2DN 959), bone-marrow derived 
mesenchymal stem cell line (hMSC), and IMR90 after 16-18 days of growth. Statistical analysis 
performed by ANOVA with Tukey’s test for multiple comparisons to the indicated groups, *p < 




Environment dependent MSC multipotency markers. 
Mesenchymal stem cell markers and their differentiation capacity into 
various stromal cell types vary greatly depending on the sites and species from 
which they are derived, and the methodology used in their isolation (Hass, 
Kasper, Bohm, & Jacobs, 2011). However, human adult bone marrow 
mesenchymal stem cells, similarly to pluripotent human embryonic stem cells, 
were previously demonstrated to express a stage-specific embryonic antigen, 
SSEA-4 (Gang, Bosnakovski, Figueiredo, Visser, & Perlingeiro, 2007). To test 
whether primary cells isolated in the microenvironment mimetic environment 
maintained multipotent characteristics similar to MSC, we assessed SSEA-4 
expression on sample 955 via immunofluorescent labeling. We confirmed that 
the majority of the cell population expressed CD90 (Fig. 19A) and observed that 
most of the cells maintained SSEA-4 expression (Fig. 19B). We also tested 
sample 927, which only produced viable progenitor cell lines in hypoxic 
environmental conditions (2DH and 3DH). We found that only the sample that 
had proliferated in the microenvironment mimetic 3DH environment maintained 
strong expression of SSEA-4 (Fig. 19C). The 3DH cells were then passaged in 
the other environments for 72 hours, and each of the environments maintained 
SSEA-4 expression. This suggests that certain characteristics induced in the 
microenvironment culture may be maintained or the rate of expression reduction 
is slowed upon transfer to traditional cell culture methods. 
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In order to verify that a physiological microenvironment indeed plays a role 
in the potency characteristics of derived cell lines, we assessed several markers 
of stem cell potency in hMSC and the 959 cell line that had been grown in the 
3DH environment. Each cell line was split to both environments and allowed to 
grow for 72 hours before collection. Cells that were maintained in the 3DH 
environment expressed higher amounts of the markers SOX2 and REX1 (also 
known as ZFP42) compared to 2DN, but Nanog and Oct4 (also known as 
POU5F1) were not significantly affected (Fig. 19A). Interestingly, when the hMSC 
were transferred to the physiological condition, SOX2 and REX1 were 
undetectable. Therefore, a physiological microenvironment mediates potency 
characteristics of primary tumor derived stromal progenitor cells but may not be 

























Figure 19. 3D Physiological hypoxia cell culture selects for SSEA4 expressing tumor 
derived stromal cells. 
A. Phase contrast and immunofluorescence staining of IMR90 lung fibroblasts and patient 
sample 955 patient tumor stromal cells for stromal marker CD90/Thy1 and nuclear stain DAPI. 
B. Staining of stromal cells and human pluripotent embryonic stem cell line H1 for stage specific 
embryonic antigen-4 (SSEA4). C. (left) SSEA4 expression of patient tumor stromal cell line 927 
derived in either 2D or 3D hypoxia. (right) SSEA4 expression of patient tumor stromal cell line 
927 3DH transferred to other environments. All scale bars are 100 µm. D. hMSC and 3DH 
derived 959 were cultured in their native culture environments or transferred for 72 hours prior 
to collection of RNA and protein for RT-qPCR and western blot. Relative expression levels of 
pluripotency markers assessed by RT-qPCR of hMSC and 3DH 959 in different environments. 





Tumor stromal cells derived in 3DH preserve tumor promoting 
characteristics. 
Given the possibility that we may have selected for an MSC subtype in our 
microenvironment mimetic culturing system, we aimed to understand whether our 
system generally activated MSC to become tumorigenic and whether tumor 
derived stromal progenitor cells also produced pro-tumorigenic factors. Thus, we 
assessed stromal genes related to worse prognosis and tumor progression in 
both cell types.  Gene expression of vascular endothelial growth factor (VEGFA) 
was significantly increased (P < 0.0368) in tumor stromal cells maintained in 3DH 
environment, but not greatly affected upon hMSC transfer to 3DH (Fig. 20A). 
Similarly, periostin (POSTN), a secreted extracellular matrix protein that plays a 
role in metastasis and is associated with a worse prognosis in a variety of 
cancers (Zhu et al., 2010), had significantly higher gene expression when tumor 
stromal cells were grown in 3DH (P < 0.0164) but was slightly decreased when 
hMSC were transferred to 3DH. Neuron-glial 2 (NG2, also known as CPSG4), an 
angiogenic pericyte protein associated with the pre-metastatic niche, and 
tenascin-C, an extracellular matrix protein frequently overexpressed in lung 
cancer, were not greatly affected by environment transfer in either hMSC or 
tumor stromal cells. Transforming growth factor beta 1 (TGF-β) was also 
increased in the 3DH environment, however when 3DH cells were transferred to 
2DN they maintained slightly higher expression (Fig. 20B). Our findings suggest 
that only tumor derived cells cultured in microenvironment mimetic culture alter 
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their phenotype to produce a variety of pro-tumorigenic factors, and we sought to 
test whether these factors might alter the phenotype of NSCLC cells themselves. 
In summary, mesenchymal stromal stem-like cells derived from early, non-
metastatic tumor resections in a microenvironment mimetic environment maintain 


















Figure 20. 3D Physiological hypoxia cell culture maintains expression of tumor 
promoting characteristics of tumor derived stromal cells. 
hMSC and 3DH derived 959 were cultured in their native culture environments or transferred 
for 72 hours prior to collection of RNA and protein for RT-qPCR and western blot. A. RT-qPCR 
of stromal derived tumorigenic factors of hMSC and 3DH 959 in different environments. B. 
Western blot analysis of HIF1-a and TGF-b expressed in 2DN or 3DH derived 959 stroma and 
transferred to different environments for 72 hours. Statistical analysis performed by ANOVA 
with Sidak’s test for multiple comparisons to the indicated groups, *P < 0.05; data presented 





Previously, we have shown that lung fibroblast derived extracellular 
matrices provide various benefits to lung adenocarcinoma cell lines in-vitro such 
as providing resistance to apoptosis, serum withdrawal and chemically induced 
hypoxia. Since the environment is a critical determinant of cell fate in NSCLC, we 
expanded our in vitro system to include a physiological oxygen tension that 
would resemble the microenvironment of the lung. Initially, we sought to test 
each individual element of our proposed microenvironment mimetic culturing 
system (Fig. 14A) and found that the individual components of hypoxia (2DH) or 
cell derived ECM (3DN) enhanced mesenchymal cell growth after 72 hours (Fig. 
14B). Interestingly, the combination of hypoxia and ECM appeared to have the 
greatest effect on cell growth. Others have demonstrated the mitogenic benefits 
of low levels of hypoxia (1-5% O2) to multiple mesenchymal cell types. Grayson 
et al. showed that hMSC grown in 2% O2 improved their cell proliferation after 
extended periods but did not enhance their proliferation rate (Grayson et al., 
2007). Instead, they concluded that hypoxia prolonged the proliferative state and 
the cells were less affected by inhibitory signaling. Our analysis of cell doubling 
time agreed with their finding as we did not observe significant differences in 
doubling time for hMSC in hypoxia, and only IMR90 fetal lung fibroblasts had a 
significantly hastened proliferation rate in hypoxia (Fig. 14C). However, all cell 
lines tested exhibited a significant reduction in doubling time when cultured in the 
combination of physiological hypoxia and ECM (3DH), suggesting that there may 
be an increase in proliferation kinetics and cell cycle progression. This is 
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supported by the relative decrease in cyclin-dependent kinase inhibitors p21-
Cip1 and p27-Kip1 in 3DH grown cells compared to 2DH (Fig 14D). This may yet 
highlight another benefit of microenvironment mimetic culturing, as these factors, 
as well as effects mediated by P53 and Akt, play important roles in the induction 
of cell senescence, a major challenge in the culture and expansion of human 
mesenchymal progenitor cells and fibroblasts (Estrada et al., 2013; Kim et al., 
2017; S. Lee et al., 2011). Indeed, we found that most cell lines tested continued 
to proliferate rapidly for more than 15 passages (Fig. 17). It is possible that the 
combined decrease in inhibition of cell cycle progression with the increased 3-
dimensional surface area allotted by the ECM act synergistically to allow 
proliferation at high cell densities, resulting in a sustained proliferative response. 
Given this sustained proliferative response, and the reported capability of 
ECM derived from desmoplastic and tumor conditioned fibroblasts to induce 
desmoplastic differentiation in stromal cells grown on those matrices 
(Amatangelo et al., 2005), we also sought to determine if our system was 
sufficient to promote desmoplastic differentiation of stroma. In accordance with 
their finding, our fibroblast derived matrix system did not induce expression of a 
desmoplastic response in normoxia or hypoxia (Fig. 14D). In addition, we found 
that cells grown in 3DH had less HIF1-a stabilization compared to their 2DH 
counterpart, indicating a role for the ECM in the regulation of the oxygen sensing 
response and homeostasis. Taken together, these data provided evidence that 
stromal cells would receive a proliferative benefit in a microenvironment mimetic 
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system and that the system may not artificially accelerate the tumorigenic 
potential of that stroma. 
Next, we obtained small tumor resections from five treatment naïve 
patients diagnosed with NSCLC (Table 3 and Fig. 17). A small portion of these 
samples was dissected, enzymatically digested, and equal quantities of cells in 
single cell suspensions were aliquoted into separate environmental conditions. 
The first of these samples, 927, was tested in each condition (2DN, 2DH, 3DN, 
3DH). After 7 days of growth, we observed cell attachment in every condition (Fig 
16A), and while there was increased cell number in 2DH and 3DN, the 3DH 
condition had a substantial increase in cells and numerous large colonies 
covering the plate. Of the environments tested, only the hypoxia environments 
were capable of cultivating cell lines. Due to the marked increase in long term 
cell viability and the limited quantities of our patient samples, we chose to 
consolidate our testing to traditional cell culture methods (2DN) or 
microenvironment mimetic methods (3DH). Further sample isolations confirmed 
our previous results, with every sample tested yielding very rapid expansion of 
cells into cell lines in 3DH compared to 2DN (Fig. 16B, and D). For one biological 
specimen, we were also able to acquire adjacent normal tissue, however we did 
not observe the same growth benefit in 3DH (Fig. 16C). It is possible that the 
number of progenitor cells present in this tissue was less than that which resides 
within the tumor microenvironment and was unable to sustain a population. 
Alternatively, stromal progenitor cells within the tumor microenvironment 
may also undergo metabolic reprogramming to allow them to adapt more easily 
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to a hypoxic cell culture system (Kalluri, 2016). Considering that we were only 
able to test one specimen, it is difficult to draw conclusions and further studies 
are required to determine the viability of 3DH culture in isolating primary human 
tissue resident stromal progenitors. Importantly, while traditional methods 
produce cell lines after a delay, 3DH isolation increases cell viability of tumor 
derived stroma, and cells isolated in this environment can be transferred to 
traditional cell culture (Fig. 16E), although at a slowed proliferation rate, allowing 
for testing via common pre-clinical research techniques. 
It should be noted that initially every sample allowed for the attachment of 
a heterogenous population of cell morphologies (Fig. 17), and some of these cell 
types were present and maintained their in-vivo cell polarity characteristics upon 
passaging in 3DH. This suggests that our microenvironment mimetic platform 
can be further manipulated to preserve other populations of cancer stem or 
progenitor cells, perhaps with supplementation of specific growth factors. 
Nonetheless, the majority cell type that proliferated was of mesenchymal origin 
(Fig. 18A) and possessed surface expression of common markers for human 
mesenchymal stem cells (Fig. 18B). Recently, there has been some discussion in 
the field of the tumor associated stroma regarding the hypothesis that cancer 
associated fibroblasts (CAF) may actually be quiescent mesenchymal stem cells 
that become activated within the tumor (Kalluri, 2016). This is supported by 
research showing that breast cancer derived CAF are remarkably similar to 
hMSC in their morphology, surface marker expression, cytokine production, and 
trilineage differentiation potential (Paunescu et al., 2011). The isolation and 
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cultivation of CAF and hMSC is also similar and dependent upon adherence to 
tissue culture plastic either from single cell suspensions or from cells that migrate 
from dissected tissue fragments. When comparing the CFU efficiency of the 
isolated cell lines, they were similar to hMSC (Fig. 18C), however the efficiency 
of at least one cell line appeared to be significantly higher when it was isolated in 
3DH compared to traditional methods. It is possible that cells isolated with 
traditional methods possess MSC-like characteristics but gradually lose them and 
progenitor capability over time, whereas cells isolated and maintained in 3DH 
preserve those characteristics. 
Multipotency is one of the defining characteristics of hMSC (Dominici et 
al., 2006). Markers associated with potency are an active area of research 
(Samsonraj et al., 2015), and these markers vary depending on the species, age, 
and tissue of origin of the isolated cells (Chamberlain, Fox, Ashton, & Middleton, 
2007; W. C. Lee et al., 2014). We found that tumor stromal progenitor cells 
cultured in 3DH expressed SSEA4 (Fig. 19B, C), similarly to hMSC derived from 
bone marrow. We did not observe expression of SSEA4 in 2DN derived samples, 
however SSEA4 was detectable when the 3DH derived cells were transplanted 
to other environmental conditions. We hypothesize that the 3DH condition selects 
for and rapidly amplifies the SSEA4 positive population, whereas this population 
grows at a delay in standard culture conditions before amplifying, similarly to 
unsorted bone marrow samples examined by Gang et al (Gang et al., 2007). 
3DH derived cells also expressed pluripotency markers Oct4, Nanog, Rex1, and 
Sox2 (Fig. 19D), however only Rex1 and Sox2 appeared to be dependent upon 
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the environmental condition of the cells. This corresponds with earlier studies of 
bone marrow MSC and embryonic stem cells grown in hypoxia (Grayson, Zhao, 
Izadpanah, Bunnell, & Ma, 2006; Westfall et al., 2008). Considering these data 
and that ECM produced by bone marrow MSC plays a pivotal role in their 
maintenance of stem-like characteristics, the combination of a native ECM and 
hypoxia seems to isolate multipotent progenitor cells from the pulmonary tumor 
microenvironment and that these cells may be MSC. 
It is well known that MSCs from the bone marrow have a remarkable 
capacity to home to tumors of a variety of different organs and affect their growth, 
as well as their response to treatment. While it is currently not possible to 
definitively identify whether the progenitor cells in the patient tumors we studied 
were tissue-resident or bone marrow derived, we asked the question of whether 
these tumor associated MSC had different tumor promoting effects compared to 
hMSC. We found that the 3DH environment significantly increased gene 
expression of angiogenesis promoting VEGF-A (Ferrara, 2004; Imoto et al., 
1998) and metastasis promoting periostin (Hong, Wei, Chen, & Shi, 2013; Zhu et 
al., 2010) in a patient derived cell line, but not in hMSC (Fig. 20A), and also 
increased TGF-β expression even after the cell line was transferred back to the 
2DN condition (Fig. 20B).  
In toto, this study demonstrates the benefits of an in-vitro culturing system 
that mimics two important elements of the tumor microenvironment, physiological 
oxygen tension and native extracellular matrix structure, in the isolation of 
stromal progenitor cells from lung tumor biopsies. These progenitor cells express 
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some commonly used markers of stem cells within our cell culture system, and 
function similarly to hMSC in supporting an in vitro tumor-like environment. We 
realize that many cells express these markers and more studies are needed to 
fully characterize their specific identity, and given our data, especially the 
potential role they may play in supporting a purported cancer stem cell 
phenotype. Indeed, our findings highlight the importance of investigation using in 
vitro models that reflect the in vivo condition as several tumor promoting 
characteristics were revealed only in physiological hypoxia and on extracellular 
matrix. Targeting factors that are producible in a physiological model may yet 
lead to greater drug targeting efficacy for future anti-tumor and anti-tumor 
associated stroma therapy. Additionally, this methodology may be refined to 
provide further insight into progenitor cells of other tissues and assist in rapidly 
expanding stem populations and preserving multipotency. 
(Saforo et al., 2019)
(Portions of this chapter are published in Scientific Reports. (Saforo et al., 2019)) 
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CHAPTER V: PATIENT DERIVED CANCER ASSOCIATED 
MESENCHMYAL STROMAL CELLS DERIVED FACTORS AND 
EXTRACELLULAR MATRIX PROMOTE METASTASIS 
INTRODUCTION 
The tumor microenvironment is composed of a diverse cellular milieu that 
acts in concert to promote a pathological environment that promotes hallmarks of 
tumor progression, including sustaining proliferative signaling, genome instability, 
inducing angiogenesis, and activating invasion and metastasis (Hanahan & 
Weinberg, 2011). Among these cellular components are transformed malignant 
cells, cancer activated mesenchymal cells or fibroblasts (CAM), endothelial cells, 
and inflammatory cells such as cancer associated macrophages. Importantly, 
each of these cell types exist in a dynamic and occasionally labile manner as 
they communicate with direct cell to cell communication or paracrine signaling. 
Indeed, the cancer associated stroma is a potent source of growth factors and 
microenvironment modifying enzymes that act both locally in the primary tumor 
and in distal sites of the pre-metastatic niche (Hoshino et al., 2015; Li et al., 
2017; Wortzel, Dror, Kenific, & Lyden, 2019). 
Recently, increased focus has delineated fibroblasts and mesenchymal 
stem cells as important mediators in the tumor microenvironment as they 
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commonly secrete these growth factors and are primary producers of 
extracellular matrix. When these cells interact with and are activated by cancer 
cells, they in turn also modulate the activity of tumor infiltrating immune cells 
including monocytes, NK cells, and macrophages, which play a role in 
extracellular matrix remodeling (Kuen, Darowski, Kluge, & Majety, 2017; Yu et 
al., 2017; R. Zhang et al., 2019). Matrix metalloproteinases (MMPs) and other 
enzymes released by cells of the tumor microenvironment degrade the ECM, but 
also activate latent growth factors and cytokines that lay dormant within the 
matrix architecture (Das, Monteiro, Barai, Kumar, & Sen, 2017; Nguyen et al., 
2016; Shay, Lynch, & Fingleton, 2015). The organization of the extracellular 
matrix as well as the dysplastic deposition of matrix proteins have been shown to 
affect the metastatic potential of tumor cells. For example, in breast cancer, 
breast density is an independent risk factor for breast cancer progression and 
cancer associated modifications to extracellular matrix, including cross-linking, 
stiffening, and alignment of collagen and other ECM proteins alter proliferation, 
migration, and invasion of breast cancer cells (Freer, 2015; Lampi & Reinhart-
King, 2018; Ondeck et al., 2019). Recently, matrikine and ECM protein profiles 
have shown promise in early diagnosis of lung cancer and as predictors of 
therapeutic benefit to adjuvant chemotherapy in early stage tumors (Andriani et 
al., 2018; Lim, Tan, Lim, & Lim, 2017). These studies demonstrate that 
alterations within the tumor microenvironment and ECM occur early during the 
progression of lung cancer, however the effect of the stromal components of 
early stage lung cancers are not completely understood.   
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Previously we demonstrated that a microenvironment mimetic cell culture 
system can amplify the isolation of a stem-like population of mesenchymal cells 
from primary tumor resections. These cells differed from bone marrow derived 
mesenchymal stem cells in their ability to respond to environmental factors such 
as physiological hypoxia and extracellular matrix, and exposure to these 
environments elicited transcription and expression of tumor promoting proteins 
including transforming growth factor-beta and the matricellular protein periostin. 
However, whether these cells were able to also affect the growth and invasion of 
cancer cells remained an unanswered question. Do these cancer associated 
cells effect the microenvironment in direct or indirect mechanisms? Are the 
responses to a “normal” stromal environment and a cancer associated stromal 
environment different in-vivo? What role does extracellular matrix remodeling 
play in the progression of cancer? 
To answer these questions, we employed physiologically relevant in-vitro 
and in-vivo models including cell-derived matrices and tumor xenograft to assess 






Cancer associated mesenchymal cells promote proliferation, invasion, and 
metastasis upon direct cancer cell interaction 
Our previous findings suggest that, unlike their bone marrow derived 
counterparts, tumor derived mesenchymal (CAM) cells cultured in 
microenvironment mimetic culture alter their phenotype to produce a variety of 
pro-tumorigenic factors (Fig. 20). We sought to test whether these factors might 
alter the phenotype of NSCLC cells themselves. 
To determine if direct interaction with patient derived stroma would alter 
cancer cell growth, we co-cultured fluorescent nuclear labeled A549 lung 
adenocarcinoma cells on different stromal monolayers. Following seven days of 
growth, A549 co-cultured with patient stroma rapidly expanded (Fig. 21A) and 
formed large, densely nucleated colonies compared to smaller, more linearly 
arranged growth on fetal lung fibroblast monolayers. This colony forming ability 
was also maintained on the MSC monolayer (Fig. 21B). Fluorescently labeled 
nuclei were quantitated and one-way ANOVA revealed that different stromal 
monolayers significantly affected the growth of A549 cells (F (6,9) = 36.51, P < 
0.0001). We found that there was no significant difference of cell growth on either 
IMR90, WI38, or hMSC monolayers, however all patient samples significantly 
increased cancer cell growth compared to lung fibroblast monolayers IMR90 and 
WI38 (955: P < 0.0088, P < 0.0495; 956: P < 0.0021, P < 0.0126; 959: P < 
0.0001, P < 0.0001; 960: P < 0.0009, P < 0.0052). Three of the patient derived 
stromal monolayers significantly increased growth compared to hMSC (956: P < 
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0.0380; 959: P < 0.0001, 960: P < 0.149). Of the patient derived cell lines, 959 
significantly increased cancer growth compared to the others (955: P < 0.008; 
956: P < 0.0023; 960: P < 0.0053). 
In order to test the ability of CAM cells to alter the invasion characteristics 
of lung cancer cells, we employed a spheroid migration assay we used 
previously to establish migration characteristics of cancer cells on CDM. Briefly, 
we grew spheroids that contained a mixture of A549 lung adenocarcinoma cells 
with either IMR90 fetal lung fibroblasts or the CAM cell line 959 (5 parts A549:1 
part stroma). Next, we transferred these spheroids to a WI38 CDM and observed 
migration for several days. Interestingly, we observed several cell migration 
modalities that we had not previously observed when growing spheroids on CDM 
with cancer cell lines alone. First, we observed that occasionally, a small cluster 
of cells would separate completely from the spheroid and the cells would migrate 
collectively in a small group away from tumor mass (Fig. 22A). Since we utilized 
the A549 cell line that stably expressed a red fluorescent protein, we were able to 
confirm that cells within this detached cluster contained a mix of cancer cells and 
stromal cells (Fig. 22A). Secondly, we also observed the formation and migration 
of long strands of connected cells that emerged from the central portions of the 
spheroid mass (Fig. 22B). These strands were present in mixed spheroids of 
both CAM and IMR90 with A549 but not in A549 spheroids alone, suggesting that 
this phenomenon is a characteristic of tumor and stromal cell interactions. Again, 
the strands appeared to have a mixed composition. Notably, both of these 
invasion modalities are characteristic of tumor invasion in-vivo (Peter Friedl & 
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Gilmour, 2009), suggesting further applications for our CDM and CAM/Cancer 
spheroid model in future studies. 
Since we observed a significant increase of cancer cell growth upon direct 
interaction with patient tumor stromal progenitors and observed invasion 
modalities characteristic of cancer cells in-vivo, we sought to determine whether 
these cells isolated and grown in 3DH also displayed pro-tumorigenic ability in-
vivo. To that end, we subcutaneously injected combinations of A549 lung 
adenocarcinoma cells and stromal cell lines, separately and co-administered 
(1:5), into flanks of immunocompromised NRG mice. After 30 days of growth, 
tumors successfully developed in all mice bearing A549 (Fig. 23A), whereas no 
tumors developed in any mice injected with only stromal cells (Fig. 23B). One-
way ANOVA comparison of mean tumor weights revealed statistically significant 
differences in tumor growth with stromal co-administered tumors (F (4,35) = 
3.710, P = 0.0128). While generally the addition of stroma resulted in increased 
tumor growth, statistically significant increases in tumor weight compared to 
solely A549 injected tumors revealed these changes may primarily be driven by 
hMSC (P < 0.0450), and 955 (P < 0.0124) co-injections. Histological sections of 
the subcutaneous tumors revealed that stromal populations were present and 
localized toward the core of tumors in co-injections (Fig. 23C), but a prominent 
stroma was not evident in the solely A549 tumors. Pulmonary histological 
analysis revealed small metastatic nodules in IMR90 co-injected mice, but 
prominent metastatic lesions in hMSC, 955, and 959 co-injected cohorts (Fig. 
23D). Pulmonary metastasis was not detected in solely A549 injected mice. In 
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summary, mesenchymal stromal stem-like cells derived from early, non-
metastatic tumor resections in a microenvironment mimetic environment maintain 
tumor promoting characteristics in-vitro and promote a full metastatic program in 















Figure 21. Cell-cell interactions between 3DH Patient derived stromal cell lines and lung 
adenocarcinoma promote cancer cell proliferation and colony formation.  
Stromal cells were grown to a confluent monolayer for four days, and then equal amounts of 
red nuclear labeled A549 cells were plated atop monolayers. A. (Upper) Phase contrast and 
fluorescent images of A549 grown on stromal monolayers of IMR90 and patient stroma 959. 
Images obtained 1 and 7 days after cancer cell seeding. (Lower) Comparison of A549 colony 
formation on IMR90 or 955 monolayers on day 7. B. Comparison of A549 colony formation on 
hMSC, 956, and 960 monolayers. C. Quantification of red nuclei on day 7 (mean nuclear counts 
were obtained from multiple images of technical duplicate plates from 2 different experiments.) 
Statistical analysis performed by ANOVA with Tukey’s test for multiple comparisons to the 
indicated groups (a: vs. IMR90, P <0.01; b: vs WI38, P < 0.05; c: vs. hMSC, P < 0.05, d: vs. 






Figure 22. Co-culture of stromal cells and cancer cells promote distinct migration 
patterns on CDM.  
Spheroids containing a mixture of red nuclear labeled A549 lung adenocarcinoma cells and 
either IMR90 or patient derived CAM (5 A549:1 Stromal cell) were grown for 4 days and then 
transferred to a WI38 CDM. Images of cell migration were captured and 4 days post transfer. 
A. Images of cells migrated from a spheroid containing A549 and IMR90 (left) and images of a 
small detached cluster that migrated from the spheroid (right). Note that areas of the detached 
cluster contain cells without red nuclei (white arrowheads). B. Comparative images of mixed 
spheroids containing CAM cell line 959 or IMR90 with A549 or A549 alone. Note the distinct 



















Figure 23. Patient derived cancer stromal cells promote metastasis in-vivo. 
955 and 959 stromal cell lines were subcutaneously injected into alone or mixed with A549 
cancer cells (5:1) and subcutaneously injected into flanks of NRG mice. IMR90 and hMSC co-
injections served as controls. A. Representative images of tumors excised after 30 days of 
growth. B. Quantification of excised tumor weights (g) (statistical analysis performed with 
ANOVA and Tukey’s test for multiple comparisons vs. A549 injection alone, *p < 0.05; data 
represented as mean ± S.E.M.) C. Histology of subcutaneous xenograft tumors. Arrows indicate 
areas of stromal cells; scale bars are 1 mm. D. Pulmonary histology of lungs from mice receiving 
xenograft tumors (left; scale bars are 1 mm). 955/A549 and 959/A549 co-injection tumor 





CAM derived extracellular matrix promotes different migration 
characteristics and molecular patterns associated with invasion 
Considering that mesenchymal cells are thought to be the major 
producers of ECM in tissue, and that we showed CAMs alter the expression of 
extracellular matrix proteins such as periostin in response to environment specific 
characteristics, we asked the question of whether CDM produced by the CAM 
cells would alter the behavior of cancers cells differently than a fetal lung 
fibroblast derived ECM we utilized for previous studies. To accomplish this task, 
we adapted our CDM protocol for use with primary CAM cells and produced ECM 
coated substrates. Visually, these matrices appeared to be more complex than 
IMR90 CDM, with fewer thick distinct bundles of matrix proteins and appeared 
less oriented, however these characteristics remain to be accurately quantified. 
We solubilized and separated the ECM produced by IMR90, as well as samples 
955, 956, 959, and 960 using SDS-PAGE and stained the total protein using 
Coomassie blue (Fig. 24A). We noted several distinct bands that were present in 
the patient samples but were not present in the IMR90 CDM, as well as an 
altered relative abundance of high molecular weight proteins. A proteomic 
analysis of the precise identification of these proteins, their abundance, 
localization, and gross linearity would likely inform future studies, however from 
our current data we can determine that each of these samples are different. In 
order to determine whether these changes in CDM could alter the migration of 
cancer cells, we transferred A549 and H2030 spheroids onto the different ECM 
and observed their migration (Fig. 24B, C). Surprisingly, with both cell lines we 
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observed decreased migration on the patient derived CDM compared to the 
IMR90 CDM. Again, we observed a directionality of migration on the patient 
derived CDM (Fig. 24C) and what appeared to be distinct “leader” and “follower” 
cell phenotypes. Qualitatively, it appeared as though the number of cells 
transitioning from collective to single cell migration was increased on the CAM 
CDM, and that the velocity of cells that separated from the mass appeared 
greater than that of cells connected to the spheroid, however we were unable to 
find a method of analyzing these parameters in an unbiased manner with 
potentially thousands of cells migrating independently. 
In an attempt to assess single cell migration behavior, we plated the 
nuclear labeled A549 cells onto the CAM CDM, IMR90 CDM, or collagen coated 
plastic (2D) and used time lapse microscopy to observe the cells in real time. 
Again, note that cancer cells grown on IMR90 CDM possess morphologies that 
resemble mesenchymal migration, with clearly polarized cell bodies that align 
themselves along the matrix and cellular projections that navigate along the 
matrix strands in an ordered fashion (Fig. 25A). Immediately, we were able to 
recognize distinct difference in cancer cells grown on the CAM CDM, where cells 
made multiple and multipronged pseudopodia adhesions to the matrix that 
appeared to be maintained for much of the observed period. Concurrently, many 
of these cells were not motile in this condition and the fluorescent nuclei 
appeared to be squeezed into oblong shapes as the cells sensed and adjusted to 
the extracellular matrix. This altered cell adhesion also appeared to affect cell 
division, as some cells on the CAM CDM would appear to enter prolonged cell 
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division and then either complete cytokinesis to emerge with multinucleated cells 
(Fig. 25B) or exit mitosis without completing cytokinesis and becoming 
multinucleated (Fig. 25C). Recently, increasing emphasis is placed on nuclear 
membrane integrity in cancer as tension and stress induced by extracellular 
forces promote nuclear membrane instability and deformability, resulting in 
genomic instability, MMP mediated invasion and associated with aggressive 
malignant disease (Denais et al., 2016; Dornier & Norman, 2018; Infante et al., 
2018). Considering that cell-matrix adhesions on all CAM CDMs appeared to be 
stable compared to the IMR90 matrix, we hypothesized that cancer cells on 
these matrices may also have sustained focal adhesion signaling. Indeed, 
western blot analysis of FAK activation showed increased phosphorylation at Tyr 
397, Tyr 925, and Tyr 576, as well as associated phosphorylation of paxillin and 
elevated expression of integrin linked kinase of cancer cells grown on the patient 
CAM CDM compared to IMR90 CDM (Fig. 26). Additionally, cancer cells 
increased activation of Src on all three patient CAM CDM, although showed little 
change in AKT from 2D conditions. Strikingly, interaction with the CAM CDM also 
greatly decreased PAI-1 expression in the cancer cells. Collectively, we have 
previously shown that this molecular pattern in A549 cells is associated with 
increased invasion into Matrigel, and here we can see that such a pattern can be 
promoted solely by interaction with extracellular matrix derived from cells isolated 









Figure 24. Patient derived CAM CDM has distinct protein composition and alters cancer 
cell migration.  
IMR90 or patient CAM cells were grown at confluence for 8 days with media supplemented with 
ascorbic acid every other day to produce CDM. Matrices were denuded of cells and then 
solubilized and separated using SDS-PAGE. A. Total proteins were visualized with Coomassie 
blue to show distinct expression patterns. A549 and H2030 lung adenocarcinoma spheroids 
were grown for six days and transferred to either IMR90 CDM, patient CAM CDM, or 2D 
collagen. B. A549 spheroids on ECM exhibited less migration on patient CAM CDM compared 
to IMR90 CDM after 120 hours. C. H2030 spheroids migrated over less total area on patient 







Figure 25. Patient CAM CDM stabilizes cell-matrix adhesions and alters cell division in 
cancer cells.  
Red nuclear labeled A549 were grown on either IMR90 CDM or patient derived CAM CDM and 
cell behavior was observed via time-lapse microscopy with images captured every 15 minutes 
for 24 hours. A. Cell morphology of A549 cells on either IMR90 CDM, with clear cell polarity 
and mesenchymal appearance, and patient derived CAM 959 CDM, with cells exhibiting 
multiple projections to the matrix and constricted nuclei. B. A cluster of A549 cells on CAM 956 
CDM demonstrates aberrant cell cycle progression with a binucleated cell (left; white arrow) 
dividing into a cell with three nuclei (right; white arrows). C. A binucleated A549 cell attempts 








Figure 26. Patient CAM CDM promotes activation of focal adhesion signaling pathways 
and an invasive molecular phenotype in cancer cells.  
A549 cells were grown on either a 2D surface, IMR90 CDM, or patient CAM CDMS (956, 959, 
and 960) CDM and lysates were collected and probed for proteins involved in focal adhesion 
signaling and 3D invasion, including focal adhesion kinase (FAK), and its phosphorylated sites 
Tyr 397, Tyr 925, and Tyr 576, integrin linked kinase (ILK), Src, activated Src (Tyr 416), AKT, 
activated AKT (Ser 473), and plasminogen activator inhibitor-1. Note that the three patient 
derived CDM similarly increase FAK and SRC activation, as well as down regulate PAI-1 




Revisiting the PAI-1 paradox using an in-vitro model of the tumor 
microenvironment 
For decades, the plasminogen-plasmin activation system has been 
intensely researched due to many elements of the system regulating tissue 
processes aside from fibrinolysis and the coagulation cascade, including cell 
senescence, proliferation, angiogenesis, and migration. Indeed, intracellular 
signaling downstream of the urokinase plasminogen activator receptor (uPAR) 
has been found to be related to activation of many integrin linked proteins found 
to be associated with tumor invasion used in this study including FAK, Src, 
paxillin, AKT, and EGFR (Mauro et al., 2017; H. W. Smith & Marshall, 2010). 
However, in a well-known paradox, PAI-1, the main inhibitor of uPAR mediated 
plasminogen activation is also associated with poor prognosis in several solid 
cancers, including breast and lung (Foekens et al., 1994; Lin et al., 2017; Look et 
al., 2002). Further, PAI-1 is expressed by adult and fetal mesenchymal stromal 
cells in the human lung (Rolandsson Enes et al., 2016). In order to understand 
the PAI-1 paradox in the context of our co-culture system of cancer cells and 
patient derived CAM cells, we first set out to verify that the stromal cells were 
also expressing PAI-1.  
We found that while lysates prepared from resected tumor material from 
patients initially had little or low PAI-1 expression, the stromal cell lines and the 
IMR90 fetal lung fibroblast cell line had relatively high expression (Fig. 27A). 
Additionally, to understand the contribution of cancer and inflammation to PAI-1 
expression in the lung, we used a repeated cisplatin dosing model in FVB mice 
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bearing lung tumors to recapitulate chemotherapeutic treatment of patients in the 
clinic (Sharp et al., 2016). Interestingly, while tumor bearing mice did not have 
different differences in PAI-1 expression in the lung, animals treated with cisplatin 
had a moderate increase in PAI-1 expression and the cohort of tumor bearing 
mice that received chemotherapy had the highest measured expression (Fig. 
27B). This lends further evidence that the stroma, and particularly the tumor 
reactive stroma, is a major contributor of PAI-1 in the tumor microenvironment. 
Next, we sought to understand the consequence of loss of PAI-1 
expression in cancer cells during co-culture of PAI-1 expressing stromal cells. 
Interestingly, we found that in the early days of co-culture, cancer cells 
segregated into small cell clusters surrounded by thick layers of stromal cells in 
an organized pattern, regardless of PAI-1 KO or overexpression in the A549 cells 
(Fig. 27C).  While this delineation was maintained after a week of co-culture in 
PAI-1 expressing A549, PAI-1 KO A549 proceeded to invade and grow into the 
stromal sections of the culture plate. These data indicate that loss of PAI-1 in 
cancer cells results in a phenotype that cannot be rescued by extracellular PAI-1 
secretion. Next, we assessed whether migration of the PAI-1 manipulated cells 
would be affected by the CAM CDM, as previously we observed a 
downregulation of PAI-1 in cells plated on the patient derived substrates. 
Previously, we found that overexpression of PAI-1 in A549 resulted in less 
spheroid migration compared to NT or PAI-1 KO on an IMR90 matrix (Fig. 13E), 
however on the CAM derived matrix we observed little difference in migration 
between the NT and PAI-1 Overexpression spheroids (Fig. 28A). As before, 
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saracatinib completely blocked migration and loss of PAI-1 expression in A549 
greatly increased spheroid migration. To model the effect of PAI-1 secretion from 
the stromal cells, we also added recombinant PAI-1 to the media of migrating 
spheroids. Interestingly, the addition of PAI-1 had the effect of enhancing cell 
migration in all the cell lines tested, with the greatest migration observed in the 
A549 PAI-1 KO cells treated with recombinant PAI-1 (Fig. 28 B, C). According to 
our previous findings, this condition of high extracellular stromal PAI-1 and low 
intracellular cancer PAI-1 expression would most accurately resemble the 
conditions of cancer cells responding to a tumor reactive extracellular matrix 
within the tumor microenvironment. Further consideration of these parameters in 
a microenvironment mimetic system may add to our understanding of the PAI-1 















Figure 27. PAI-1 is expressed by cells of the tumor stroma, and loss of PAI-1 in cancer 
cells promotes invasion into tumor stroma.  
To assess the expression of PAI-1 in stromal cells, we used the CRISPR/cas9 lentivirus 
containing guides for PAI-1 to stably modify the fetal lung fibroblast cell line IMR90, and probed 
for PAI-1 via western blot analysis (left). In addition, we compared the total PAI-1 expression in 
lysates derived from the primary tumor resections from patients and compared them to the CAM 
cell lines derived from those tumors (right). Gapdh was used as a loading control. B. PAI-1 
mRNA expression was measured in the lung of FVB mice 8-weeks of age (Y) or middle-age (6-
months old) (M) with or without non-small cell lung carcinoma and treated with 4-doses of 
vehicle or cisplatin, 1-wk apart and sacrificed 72 hr after the last injection, demonstrating 
increased PAI-1 expression in a physiologically relevant cancer model in-vivo. C. Images of co-
culture of CRISPR KO or overexpressed PAI-1 A549 cells and WT IMR90 fibroblasts (10:1) 2 
and 7 days post culture. Note delineated tumor margins in NT and PAI-1 expressing A549 while 






Figure 28. Exogenous PAI-1 promotes spheroid migration on CAM CDM.  
CRISPR/cas9 PAI-1 KO, NT, and PAI-1 overexpressing A549 were grown in spheroids and 
then transferred onto CDM produced by either patient CAM cell lines 959 or 960. A. 
Quantification of cell migration from PAI-1 manipulated spheroids treated with either vehicle or 
saracatinib (5 µM) 72 hours after transfer to CDM. To assess the role of non-tumor derived PAI-
1 on cell migration, NT, PAI-1 KO (B) and PAI-1 overexpressing spheroids were transferred to 
a WI38 CDM and treated with complete media, saracatinib (5 µM), or recombinant human PAI-
1 (1.33 µg/mL) and images were captured at 72 hours. C. Quantification of spheroid migration. 




In the present study, we assessed the contributions of tumor derived 
stroma in affecting the metastatic characteristics of lung adenocarcinoma cells. 
To accomplish this goal, we used cell lines that were derived from tumor 
resections from patients with treatment naïve early stage lung cancer (Table 3). 
Previously we established that several genes associated with tumor progression 
and stemness were upregulated in these cells in an environment dependent 
manner, where a microenvironment mimetic culture system stimulated many of 
these factors (Fig. 20). We employed direct co-culture of A549 cells with primary 
tumor stroma or fetal lung fibroblast cell lines to test the effects of the tumor 
derived cells on cell proliferation. Patient stroma also significantly increased 
A549 lung adenocarcinoma cell growth in this direct co-culture model in-vitro 
compared to hMSC and fetal lung fibroblasts (Fig. 21C). Interestingly, A549 
clustered into dense nests of cells when cultured on hMSC or patient stromal 
monolayers, but not on the fibroblast monolayers (Fig. 21A, B). These cell nests, 
as well as nests observed in early culture of NSCLC derived cell lines (Fig. 17), 
resembled sphere forming cancer stem cells (CSC) induced in a CSC/CAF co-
culture system (W. J. Chen et al., 2014). It is possible that the microenvironment 
mimetic culture method also plays a role in establishment or maintenance of 
CSC populations, especially in the context of additional paracrine signaling with 
tumor stroma. Since CAF have been demonstrated to produce exosomes that 
regulate tumorigenic properties of other cancers, it would be interesting to know 
whether direct interaction of cancer cells with tumor stroma is required to incite 
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these properties or treatment of conditioned media from the stroma is sufficient to 
alter cell proliferation and stem-like characteristics (Richards et al., 2017).  
Remarkably, while co-culture of cancer cells and stromal cells didn’t 
drastically alter spheroid morphology, transfer of these spheroids to extracellular 
matrix revealed some intriguing differences in collective cell migration. While we 
had observed cell streaming from spheroids in a collective manner previously, 
upon co-culture we witnessed collective migration phenotypes normally observed 
in-vivo including the migration of cells in small, separate clusters or in long, thin 
strands that remained connected to the spheroid mass (Fig. 22). Fluorescent 
imaging showed that these multicellular structures contained a majority of cancer 
cells with a small quantity of stromal cells dispersed in between. Future in-vitro 
studies may focus on elucidating the molecular mechanisms underlying this 
association of cells as these structures are proposed to play a role in the survival 
of circulating tumor cells to promote metastasis (Clark & Vignjevic, 2015; 
Fabisiewicz & Grzybowska, 2017; Giuliano et al., 2018).  
As we established that stromal cells potentiate tumor migration patterns 
in-vitro that are normally observed in-vivo, we asked the question of whether 
these tumor-stromal cell interactions would drive tumor growth and metastasis in-
vivo. To understand these interactions in vivo, xenograft studies demonstrated 
that subcutaneous co-injection of A549 with stroma significantly increased tumor 
size compared to A549 alone (Fig. 23A, B), and that this stroma remained 
present and localized toward the core of the tumor (Fig. 23C). Further, both 
cohorts of mice bearing patient stromal tumors developed metastasis to the lung, 
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similarly to hMSC injected mice while not in A549 alone (Fig. 23D). This suggests 
that patient stroma can promote a normally non-metastatic cancer cell line to 
undergo the full metastatic process. 
Whether this effect is due to the increased expression of stromal TGF-β, 
VEGF-A, periostin, or another stromal derived factor remains to be elucidated. 
However, we did find that we were able to use our CDM model to create 
extracellular matrices from the patient derived stromal cell lines. Interaction with 
the extracellular matrix alone altered the normal 3D migratory behavior and 
promoted an invasive phenotype in the cancer cells. Specifically, we observed 
sustained cell-matrix adhesions and focal adhesion signaling (Fig. 25). This led 
to reduced migration and errors in cell proliferation as cells divided and became 
multinucleated. Considering that the ECM produced by fetal lung fibroblasts and 
primary tumor stromal cells is different (Fig. 26), an understanding of the specific 
ECM proteins interacting with cancer cells, as well as other physical 
characteristics of the CAM CDM are warranted. Targeting these adhesion 
mechanisms or the downstream signaling cascades following their interaction 
may provide therapeutic benefits to early stage cancer patients to help limit 
progression. Additionally, we have not yet tested the ability of these CAM CDM to 
promote tumorigenic characteristics in non-transformed lung epithelial cells. Are 
these invasive responses due to sustained signaling downstream of oncogenes 
such as KRAS or are they independent of driver mutations and a general feature 
of cell interaction with a cancer associated ECM? Do cancer cells also contribute 
to the remodeling of the ECM produced by a tumor reactive stroma? 
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A hint toward the latter question was revealed when we found that PAI-1 is 
downregulated in cancer cells that interact with a CAM CDM (Fig. 26). PAI-1 
prevents pericellular proteolysis and ECM degradation mainly through inhibiting 
the action of plasmin, and downregulation of PAI-1 may lead to an imbalance of 
the plasminogen-plasmin system within the tumor and may promote local 
remodeling. However, we also see that stromal cells within the lung tumor 
produce PAI-1 in the tumor microenvironment, and when we knocked out PAI-1 
in the tumor cells, we still observed an invasive phenotype into the stroma (Fig. 
27). Addition of recombinant PAI-1 also promoted migration on ECM, suggesting 
that extracellular PAI-1 may enhance cancer cell motility regardless of the 
expression of the cancer cells (Fig. 28). The cell intrinsic and extrinsic effects of 
PAI-1 may potentiate each other to promote an invasive phenotype. Takashi 
Yahata et al. found that intracellular, but not extracellular, PAI-1 inhibited the 
cleavage and activation of the pro-peptide of MT1-MMP by the proprotein 
convertase furin in murine hematopoietic stem cells (Yahata et al., 2017). A 
similar mechanism may be occurring in cancer cells. Further molecular 
characterization of invasion associated genes, as well as understanding of post-
transcriptional regulation of PAI-1 on cancer CDM, would provide valuable insight 
to the PAI-1 paradox in lung cancer. Development of therapeutics to inhibit the 
extracellular effects of PAI-1 may therefore be worthwhile to investigate. 
Alternatively, restoring PAI-1 expression in cancer cells may also prevent the 
invasive phenotype observed. To test this hypothesis would require a transient 
138 
 
CRISPR/Cas9 editing system that would enable stable genetic knockout and 
plasmid mediated exogenous expression. 
This work further enables the clinically relevant study of patient specific 
tumor features that are sufficient to promote tumor growth and metastasis. 
Interactions with primary stromal cells from lung tumors, even from patients that 
clinically do not present with metastasis, are capable of promoting metastasis in 
a xenograft model. We see that the extracellular matrix produced by these cells 
is different, and that this matrix can modulate cell behavior and protein 
expression. On the other hand, an equally important question that remains to be 
addressed is what factor in the tumor microenvironment of these early stage 
patients is sufficient to impede the tumor promoting characteristics we see from 
the cancer associated ECM? How are these factors lost in the course of cancer 
progression, and could their restoration prevent metastatic dissemination and 
disease in late stage patients? Targeting factors that are producible in a 
physiological model may yet lead to greater drug targeting efficacy for future anti-





CHAPTER VI:  SUMMARY AND CONCLUSIONS 
 
The overall goal of this dissertation was to determine how ECM interactions with 
lung adenocarcinoma cells can promote hallmarks of cancer metastasis in a 
physiologically relevant in vitro model that included a lung fibroblast cell-derived 
extracellular matrix (CDM) and physiological levels of hypoxia that approximate 
the  amount of oxygen present in the lung microenvironment. This work 
continued from a study previously performed by Scherzer et al. that 
demonstrated that lung adenocarcinoma cells cultured on a CDM altered their 
morphology, proliferation, migration, and survival to serum withdrawal (Scherzer 
et al., 2015). Additionally, he performed a microarray study which compared the 
gene expression of two lung adenocarcinoma cell lines, A549 and H358, on two 
different CDM and a 2D fibronectin coated surface. These data allowed for us to 
answer more specific questions regarding the regulation of molecular interactions 
that occur when cells encounter extracellular matrix. 
 We were able to identify integrin signaling as a key component of 
extracellular matrix interaction in lung adenocarcinoma cells in promoting 
migration and EMT. Activation of Src family kinases was required for 3D enabled 
migration and invasion. Interaction with 3D CDM in a process that appeared to 
be downstream of integrin binding to fibronectin through an RGD motif switched 
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the modality of migration and potentiated invasion into Matrigel. This process 
was also associated with protease activity under the regulation of PAI-1. 
Inhibition of Rho/ROCK inhibits the activation of MLC and promoted similar 
invasion of 2D cells as cells on 3D CDM. Together, these data suggest that lung 
cancer cells on a 3D CDM utilize a mesenchymal mode of migration to facilitate 
invasion (Fig. 29). 
 We also utilized a microenvironment mimetic culture system that included 
the combination of 3D CDM and physiological hypoxia to greatly amplify the 
isolation and proliferation of cells from enzymatically digested primary human 
tumor resections. We extensively characterized the cell populations that derived 
under this condition as a cancer associated mesenchymal stem-like cell, and we 
found that these cells produced tumorigenic factors in an environment dependent 
manner unlike their bone marrow derived counterparts. This environment was 
also critical in maintenance of stem potency gene expression and may be used in 
the future to isolate rare progenitor cell populations from other tissues. 
 Finally, we assessed the ability of these primary tumor resected stromal 
cells to affect lung adenocarcinoma growth and metastasis. These cells 
stimulated cancer cell proliferation in-vitro and could promote a full metastatic 
cascade in a xenograft mouse model using a normally non-metastatic human 
lung adenocarcinoma cell line. We established 3D CDM from these cells and 
identified that their ECM differs from fetal lung fibroblast CDM in composition and 
in function of altering the phenotype of cancer cells. Lung adenocarcinoma cells 
on patient stromal CDM stabilized focal adhesions, displayed slowed migration 
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and nuclear instability, and demonstrated a highly invasive molecular profile with 
increased Src activation and decreased intracellular PAI-1. Interestingly, these 
stromal cells also produce and secrete PAI-1 into the extracellular environment. 
We found that migration of cancer cells genetically deficient in PAI-1 was 
increased on 3D CDM following addition of recombinant PAI-1 protein to the 
media. These findings suggest a novel possible explanation for the PAI-1 
paradox, in which cancer associated stroma produces extracellular matrix that 
results in the downregulation of PAI-1 within the cancer cell, and supports cancer 
cell migration by secreting PAI-1 into the tumor microenvironment. 
 In conclusion, we identified molecular mechanisms that promote cancer 
metastasis in-vitro and in-vivo through extracellular matrix interactions in the 
tumor microenvironment. Further understanding of these interactions and specific 
microenvironment related targets may lead to improved therapeutics for lung 
cancer patients suffering from or at risk of developing metastatic disease. 
Strengths 
We utilized a physiologically relevant in-vitro model of lung cancer in order to 
explore molecular targets with possible in-vivo significance. This 
microenvironment mimetic model provided us with new information about the 
modality of migration and invasion in lung cancer cells that is triggered upon 
interaction with a physiological extracellular matrix substrate. In a direct test of 
this system, we were able to improve the isolation and proliferation of primary 
cells derived from patients with early stage lung cancer and demonstrated that 
these cells promote metastasis in an in-vivo model. The techniques utilized in 
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this dissertation can be widely applied to cancers of other tissues and are highly 
reproducible. 
Limitations 
One of the benefits of the 3D CDM system is that it is highly amenable to light 
and fluorescent microscopy. Data produced from this dissertation suggested that 
collectively migrating cells are highly diverse and exhibit a “leader and follower” 
phenotype. However, a majority of the assays used sampled the entire 
population of cells rather than those at the leading edge of cell migration that 
may be biologically significant. Further exploration of the localization and 
phosphorylation of important proteins in integrin signaling and their interactors 
utilizing techniques such as Fluorescence resonance energy transfer (FRET) 
microscopy and fluorescence recovery after photobleaching (FRAP) may provide 
illuminating information in the search for precise molecular targets. Additionally, 
all lung adenocarcinoma cell lines used in this study harbored KRAS mutations, 
which only accounts for around 30% of lung adenocarcinoma. Study of cell lines 
possessing different driver mutations may provide information on whether the 
increased invasion observed with contact with 3D CDM is a RAS specific effect 
















Figure 29. Model of cell-matrix interactions and signaling pathways that promote 
migration and invasion on CDM. 
Cancer cells grown on 2D substrates differ in their ability to promote migration and invasion 
compared to cells interacting with 3D CDM. A. Focal adhesion signaling downstream of RGD 
binding integrin through FAK and Src family kinases is required for 3D cell migration and EMT. 
Inhibition (i) of Src results in stabilization of E-cadherin, upregulation of protease inhibitors, and 
decreased invasion, but ERK and AKT activation may be supported by alternative mechanisms. 
B. Lung cancer cells on 3D CDM downregulate MLCK. Inhibition of RhoA/ROCK signaling 
phenocopies the invasive phenotype to cancer cells grown on 2D. This suggests contact with 
3D CDM may alter the balance of cytoskeletal remodeling to favor actin polymerization over 
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